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ABSTRACT 
 
  The nervous system is a complex network of a large number of neurons, and the 
neuronal communication between these cells often relies on chemical signals. 
Deciphering these signaling molecules, including neuropeptides, is an important but 
challenging task. Microfluidic technology allows the manipulation of mass-limited 
samples and the control of the extracellular microenvironment, making it well suited for 
studying neurons. In this work, we developed several microfluidic devices that can be 
interfaced to matrix-assisted laser desorption/ionization (MALDI) mass spectrometry 
(MS) for characterization of neuropeptide release in response to chemical stimulation. 
One of the microdevices contains an inlet reservoir connected to three sampling channels. 
Neurons are loaded into the inlet, and the surrounding chemical environment is precisely 
controlled. The analytes are collected onto a derivatized surface as the media in the 
reservoir flow through the channel. After that, the surface is interrogated with offline 
MALDI-MS imaging. This device allows the temporal analysis of the stimulation event, 
by sequentially sampling the media in different channels. In another device, one single 
neuron is loaded inside the microchannel, and the releasate is collected in the downstream, 
enabling single cell analysis. Microfluidics even allows subcellular regions of a neuron to 
be separately manipulated. In the compartmentalized device, three parallel large channels 
are connected by small interconnects, and under appropriate conditions, the neurites from 
cells loaded into the main channel can grow through the interconnects and enter into the 
adjacent channels. The fluidic environment in each channel can be individually controlled. 
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This dissertation also presents a unique method to quantify peptides based on the 
adsorption length in a microchannel. The device used here contains a cell chamber and a 
long serpentine channel. As the ability of a surface to adsorb an analyte is fixed per area, 
a larger amount of analyte covers a longer section of the channel. Experiments with 
standards confirmed the expected linear relationship of the sample amount and the 
adsorption length. By applying this approach to a small number of Aplysia bag cell 
neurons, the determined amounts of peptides released from a single neuron agreed with 
other methods. Our quantitation method provides a simple, label-free, and robust way for 
quantitation of mass-limited samples within microfluidic devices. 
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my parents and family 
 
 
v 
 
ACKNOWLEDGEMENTS 
 
 I would like to take the opportunity here to express my deepest gratitude to 
everyone who has been supporting my Ph.D. studies at the University of Illinois, Urbana-
Champaign. First of all, I would thank my supervisor, Prof. Jonathan V. Sweedler, for his 
always support and guidance during my research. He is very knowledgeable and knows 
how to encourage students when they encounter difficulties. I appreciate all the insightful 
suggestions he gave to me to make my dissertation research so smooth. He is a good 
teacher. I learned a lot from him about how to address research topics in a systematic and 
scientific way. Moreover, I want to thank him for giving me the flexibility to try different 
approaches during my Ph.D. research. 
 I enjoy every moment I have spent at the Sweedler group. The group members 
here are always willing to offer help when needed. I want to specially thank Dr. Chang 
Young Lee for his technical assistance to my research projects. He is very intelligent and 
knows a lot about engineering. I know whenever I need help, I can get it from him. It has 
been my great pleasure to work with him for the past two years. I am also thankful to Dr. 
Kyubong „Q” Jo and Dr. Michael L. Heien, our previous group members, for introducing 
me into this research subject and training me on how to make microfluidic devices and to 
use the mass spectrometer when I first started the research. The members of the 
microfluidics subgroup also include Callie Croushore, Sam-ang Supharoek, and Amy 
Maduram, who are extremely helpful and willing to share their expertise, during 
cooperation as well as the monthly subgroup meeting. They are not only my coworkers, 
but also my personal friends. Besides, I am grateful to Dr. Stanislav S. Rubakhin and Dr. 
vi 
 
Elena Romanova for their helpful discussions on cell manipulation, and Stephanie Baker 
for editing my manuscripts. Of course, I also acknowledge all the Sweedler group 
members, for their kindness and support throughout my Ph.D. studies. 
 My research work involved cooperation with the Gillette and Nuzzo groups at 
UIUC. I want to thank Dr. Larry J. Millet and Anika Jain from the Gillette group for 
sharing their expertise in PDMS extraction and cell handling, and Dr. Matthew E. Stewart 
and Audrey Bowen from the Nuzzo group for assistance in device fabrication. I am very 
thankful to Kathleen Motsegood, who manages the clean room at the Beckman Institute, 
for all the training and support I received from her. 
 I would also want to express my appreciation to Prof. Ryan C. Bailey, Prof. 
Martha U. Gillette, and Prof. Ralph G. Nuzzo for serving on my dissertation committee 
and for offering insightful and helpful advice on my literature seminar, preliminary exam, 
and original research proposal.  
 Last but not the least, I would give my special and sincere gratitude to my parents 
and my wife. I am the only child of my parents, and I understand they have dedicated all 
themselves to my personal growth. From them, I have learned how to face challenges, to 
appreciate the life we have, and to be optimistic about the future. Speaking with them on 
the phone every Friday night is the happiest time of my life in the US. 
vii 
 
TABLE OF CONTENTS 
 
LIST OF TABLES ........................................................................................................... xi 
 
LIST OF FIGURES ........................................................................................................ xii 
 
CHAPTER 1: INTRODUCTION AND DISSERTATION OVERVIEW ................... 1 
1.1 Background ................................................................................................................ 1 
1.2 Introduction to Microfluidics..................................................................................... 2 
1.3 Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry 
(MALDI-TOF MS) and MALDI Imaging....................................................................... 5 
1.4 Interfacing Microfluidic Devices with MS ................................................................ 8 
1.4.1 ESI Interfaces ...................................................................................................... 9 
1.4.2 MALDI Interfaces ............................................................................................. 12 
1.4.2.1 Offline Interface to MALDI by Deposition ............................................... 13 
1.4.2.2 Offline Interface to MALDI by Using the Microfluidic Chip as the Target
 ................................................................................................................................ 14 
1.4.2.3 Online Interface to MALDI ........................................................................ 16 
1.5 Dissertation Overview ............................................................................................. 17 
1.6 Figures ..................................................................................................................... 21 
1.7 References ............................................................................................................... 22 
 
CHAPTER 2: MASS SPECTROMETRIC IMAGING OF PEPTIDE RELEASE 
FROM NEURONAL CELLS WITHIN MICROFLUIDIC DEVICES ..................... 28 
2.1 Notes and Acknowledgements ................................................................................ 28 
2.2 Introduction ............................................................................................................. 29 
2.3 Experimental ............................................................................................................ 32 
2.3.1 Materials and Reagents ..................................................................................... 32 
2.3.2 Device Fabrication ............................................................................................ 32 
2.3.3 Surface Derivatization ....................................................................................... 33 
viii 
 
2.3.4 Biological Experiments ..................................................................................... 34 
2.3.5 Mass Spectrometric Imaging ............................................................................. 35 
2.3.6 Surface Coverage Measurement Using Radioisotope Labeled Molecules ....... 35 
2.4 Results and Discussion ............................................................................................ 36 
2.4.1 Sampling from a Functionalized Surface .......................................................... 36 
2.4.2 Surface Coverage .............................................................................................. 38 
2.4.3 Comparison of Different Derivatized Surfaces ................................................. 40 
2.4.4 Neuropeptide Release ........................................................................................ 42 
2.4.5 Single Cell Analysis .......................................................................................... 43 
2.5 Conclusions ............................................................................................................. 44 
2.6 Tables and Figures ................................................................................................... 46 
2.7 References ............................................................................................................... 57 
 
CHAPTER 3: QUANTITATION OF PEPTIDE RELEASE FROM NEURONS.... 60 
3.1 Notes and Acknowledgements ................................................................................ 60 
3.2 Introduction ............................................................................................................. 61 
3.3 Experimental ............................................................................................................ 64 
3.3.1 Materials and Reagents ..................................................................................... 64 
3.3.2 Substrate Derivatization .................................................................................... 65 
3.3.3 Device Fabrication ............................................................................................ 65 
3.3.4 Scintillation Measurements of Peptide Absorption ........................................... 66 
3.3.5 Standard Peptide Calibration Experiments ....................................................... 66 
3.3.6 Cell Experiments ............................................................................................... 67 
3.3.7 MS Imaging ....................................................................................................... 68 
3.4 Results and Discussion ............................................................................................ 68 
3.4.1 Minimizing Peptide Losses to PDMS ............................................................... 68 
3.4.2 Minimizing Peptide Losses to Reservoir .......................................................... 70 
3.4.3 Device Design and Fabrication ......................................................................... 72 
3.4.4 Modeling the Molecular Adsorption and Separation in Microchannels ........... 75 
3.4.5 Validation of the Model with a Single Standard ............................................... 78 
3.4.6 Validation of the Model with Multiple Standards ............................................. 81 
ix 
 
3.4.7 Measuring Neuronal Release ............................................................................ 82 
3.5 Conclusions ............................................................................................................. 83 
3.6 Figures ..................................................................................................................... 85 
3.7 References ............................................................................................................. 101 
 
CHAPTER 4: COMPARTMENTALIZED DEVICE FOR CONTROLLING AND 
SAMPLING SUBCELLULAR MICROENVIRONMENTS SURROUNDING 
NEURONS ..................................................................................................................... 104 
4.1 Notes and Acknowledgements .............................................................................. 104 
4.2 Introduction ........................................................................................................... 104 
4.3 Experimental .......................................................................................................... 107 
4.3.1 Materials and Reagents ................................................................................... 107 
4.3.2 Glass Surface Treatment ................................................................................. 108 
4.3.3 Device Fabrication .......................................................................................... 109 
4.3.4 Solvent Extraction of PDMS ........................................................................... 110 
4.3.5 Neuron Isolation and Loading ......................................................................... 110 
4.3.6 Culturing Neurons inside Microchannels ........................................................ 111 
4.4 Results and Discussion .......................................................................................... 112 
4.4.1 Device Design ................................................................................................. 112 
4.4.2 Controlling Flows in Individual Microchannels ............................................. 112 
4.4.3 Introducing Neurons into Microchannel ......................................................... 114 
4.4.4 Increasing Neuron Viability inside Microchannels ......................................... 115 
4.4.5 Patterning Glass Surfaces with PLL/BSA for Guidance of Neuronal Growth 
 .................................................................................................................................. 116 
4.5 Conclusions ........................................................................................................... 117 
4.6 Figures ................................................................................................................... 119 
4.7 References ............................................................................................................. 128 
 
CHAPTER 5: CONCLUSIONS AND FUTURE WORK ......................................... 130 
5.1 Figures ................................................................................................................... 138 
x 
 
5.2 References ............................................................................................................. 139 
 
APPENDIX A: LIST OF ABBREVIATIONS ........................................................... 140 
 
APPENDIX B: FABRICATION PROCESS OF MICROFLUIDIC DEVICES..... 142 
 
xi 
 
LIST OF TABLES 
 
Table 2.1 Adsorption of radiolabeled cytochrome c onto a hydrophobic surface ........... 46 
xii 
 
LIST OF FIGURES 
 
Figure 1.1 Schematics of MALDI-TOF MS .................................................................... 21 
Figure 2.1 Fabrication process of PDMS microfluidic device ......................................... 47 
Figure 2.2 Experimental overview of the process of collecting and measuring neuronal 
analysis using a microfluidic device ................................................................................. 48 
Figure 2.3 Sampling peptides on a functionalized surface using a microfluidic device .. 49 
Figure 2.4 Depletion of angiotensin II along a serpentine channel ................................. 50 
Figure 2.5 MS images of substance P drawn through the serpentine channel ................. 51 
Figure 2.6 MS images of 5 ng substance P on silicon surfaces derivatized with different 
reagents ............................................................................................................................. 52 
Figure 2.7 MS images of peptides on silicon surfaces derivatized with DMOPAC ........ 53 
Figure 2.8 Temporal analysis of released neuropeptides from five Aplysia bag cell 
neurons stimulated using potassium ................................................................................. 54 
Figure 2.9 Analysis of release from a single Aplysia bag cell neuron ............................. 56 
Figure 3.1 Fabrication process of a silicon surface patterned with OTS and OEG ......... 85 
Figure 3.2 Radiolabeled Angiotensin II peptide recoveries following 4 h incubations 
from PDMS subjected to different treatments, as well as the control solution before 
incubation .......................................................................................................................... 86 
Figure 3.3 Removal of OTS in the reservoir with oxygen plasma treatment .................. 87 
Figure 3.4 Partial coating of silicon with OTS ................................................................ 88 
Figure 3.5 The method of gold patterning to reduce nonspecific adsorption in the 
reservoir area ..................................................................................................................... 89 
Figure 3.6 Device design. The microfluidic device contains a long serpentine channel . 90 
Figure 3.7 Influence of the reservoir size on adsorption length....................................... 91 
Figure 3.8 MS images of 5 pmol AP flowing through the channel on different surfaces 
........................................................................................................................................... 92 
Figure 3.9 A simple kinetic model describes the molecular adsorption in the microfluidic 
device ................................................................................................................................ 93 
Figure 3.10 Influence of concentration and flow rate on length measurements .............. 94 
xiii 
 
Figure 3.11 Reproducibility of quantitation approach in different devices ..................... 95 
Figure 3.12 Characterization of AP peptide via MS imaging of the microfluidic device 
substrate ............................................................................................................................ 96 
Figure 3.13 Intensity profile of 10 pmol AP along the channel ....................................... 97 
Figure 3.14 MS imaging of two peptides (AP and αBCP) from the microfluidic substrate
........................................................................................................................................... 98 
Figure 3.15 Comparison of MS images with AP alone and with the coexistence of AP 
and αBCP .......................................................................................................................... 99 
Figure 3.16 Aplysia bag cell release experiments with the microfluidic device ............ 100 
Figure 4.1 Mask design of the device used to pattern glass with repeated lines of PLL 
and BSA .......................................................................................................................... 119 
Figure 4.2 Fabrication process of compartmentalized microfluidic device ................... 120 
Figure 4.3 Design of compartmentalized microfluidic device ....................................... 121 
Figure 4.4 Controlling flows in individual channels ..................................................... 122 
Figure 4.5 Loading neurons into microchannel ............................................................. 123 
Figure 4.6 Loading neurons into microchannels with pipette ........................................ 124 
Figure 4.7 Growth of Aplysia bag cell neurons on different surfaces ............................ 125 
Figure 4.8 Culturing Aplysia bag cell neurons in microchannels .................................. 126 
Figure 4.9 Patterning PLL/BSA lines on glass .............................................................. 127 
Figure 5.1 Design of microfluidic devices for future work ........................................... 138 
 
1 
 
CHAPTER 1 
 
INTRODUCTION AND DISSERTATION OVERVIEW 
 
 
1.1 Background 
  In the nervous system, a large number of neurons form a complex highly-
branched network. For example, the human brain contains about 10
12
 neurons with the 
estimated number of 10
15
 connections.
1
 Neuronal communication often relies on 
chemical signals. Knowledge of a complement of these signaling molecules provides 
novel insights into the key effectors in neuronal repair and restoration of function, and 
provides clues to the possible treatments of neurodegenerative diseases, which are of 
rising concern with the aging of our population. In the Sweedler group at the University 
of Illinois, Urbana-Champaign, we are interested in understanding the detailed chemical 
information contained in neuron-neuron interactions by using a broad array of analytical 
techniques and different model organisms. 
 The specific category of signaling molecules I have been studying is 
neuropeptides. In a neuronal network, peptides can function as neurotransmitters (act on 
neurons in the immediate vicinity), neuromodulators (influence the response of a neuron 
to an input), neurohormone (function at a distance from the sites of release), or trophic 
factors (stimulate neuronal growth).
2
 Investigation of peptide release presents challenges 
due to their small amounts and structural diversity. The overarching goal of my 
dissertation research is to develop suitable microanalytical platforms to define and 
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sample extracellular environments surrounding neurons, down to subcellular regions, for 
determination of identities, quantities, and dynamics of neuropeptide release. The 
primary technology utilized in this research is microfluidics, since microfluidic 
technology is well suited for manipulation of small-volume samples and control of local 
chemical environment with high spatial resolution. For detection of neuropeptides, mass 
spectrometry is used due to its rich information content and high sensitivity. We have 
selected Aplysia californica as the model organism to validate our microfluidic systems 
because of its well-characterized nervous system and biochemical properties. In 
particular, bag cell neurons from the Aplysia abdominal ganglion can be stimulated with 
an elevated potassium concentration, leading to depolarization of the cell membrane and 
release of several known neuropeptides.
3, 4
 
 
1.2 Introduction to Microfluidics 
 Since microfluidics was first introduced
5
, it has been used throughout analytical 
chemistry and biological sciences.
6
 Microfluidics, by broad definition, is a technology 
that utilizes fluids contained in the micron scale. Because of the small sizes, microfluidic 
technology offers advantages such as control of local microenvironment, manipulation of 
small-volume samples, minimal reagent consumption, portability, and integration of 
multiple components in a single device, enabling “lab on a chip”.6, 7 The advantages of 
microfluidics lies on the distinct fluidic characteristics associated with the small 
dimension of the microchannel. A good understanding of fundamentals of fluid 
mechanics in the microfluidic system helps in design of microfluidic chips tailored to 
specific applications. Here I present some of the most important principles and equations 
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for microfluidics pertinent to this dissertation. For detailed description of fluid mechanics, 
please refer to Ref. 8. 
The most prominent phenomenon of fluids in the microchannel is the laminar 
flow. The behavior of mass transfer in a flow is determined by the Reynolds number, 
which describes the ratio of inertial forces to viscous forces, is defined as
8
: 

dv
Re                                                                                                                        (1.1) 
where Re is the Reynolds number, d is the hydraulic diameter of fluid, v is the velocity, ρ 
is the density, and μ is the viscosity. As the diameter of the microchannel is small, 
usually Re is well below the transition region. Therefore, under typical flow conditions, 
the flow in the microchannel is laminar, in which the fluids move in parallel layers 
without convective mixing between layers. The mixing perpendicular to the flow 
direction is by diffusion only. When considering mass transfer in a microfluidic device, 
the effects of diffusion must be taken into account. The average one-dimensional 
diffusion distance of a molecule, L, is
8
: 
DtL 2                                                                                                                        (1.2) 
in which D is the diffusion coefficient and t is the time. In studies relying on the substrate 
surface to adsorb molecules flowing in the microchannel, the flow rate needs to be slow 
enough to allow molecules on top of the channel to diffuse to the bottom. In a pressure 
driven flow, the flow rate in volume, Q, is
8
: 
R
P
Q

                                                                                                                            (1.3) 
in which ΔP is the pressure difference applied across the channel and R is the channel 
resistance. R in a circular channel can be calculated as
8
: 
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4
8
r
L
R


                                                                                                                          (1.4) 
where μ is the viscosity, L is the channel length, and r is the radius of the channel. As the 
size of the channel decreases, its resistance increases dramatically. In addition to the 
fluidic properties mentioned above, surface area also becomes an important factor as the 
surface area to volume ratio increases with shrinking dimension. Therefore, in the 
microchannel, the adsorption/absorption of analytes onto the channel wall and the 
capillary force are usually significant.
8
 
 Microfluidic devices can be fabricated with a broad array of materials, such as 
hard materials like silicon and glass. Polymer-based devices have become increasingly 
popular to biological applications. In particular, polydimethylsiloxane (PDMS), a silicone 
elastomer, is frequently used because of its optical transparency, flexibility, and gas 
permeability that allows respiration of cells in contact with PDMS.
9
 Moreover, the 
surface properties of PDMS, such as the hydrophobicity and the capability of adhesion of 
biomolecules and cells, can be tailored to the requirements of specific applications by 
treatment with different protocols.
10
 Fabrication of PDMS devices is a simple and 
inexpensive process.
11
 Typically, PDMS devices are made by molding on a master with 
the photoresist pattern on it. The photoresist used with PDMS is usually a negative 
epoxy-based one, SU-8, due to its rigidity after polymerization. The master is fabricated 
with photolithography, in which the SU-8 layer spin-coated on a silicon wafer is exposed 
to UV light (e.g. mercury lamp) through a photomask. A large number of PDMS devices 
can be made from a single master, lowering the cost of fabrication. Due to the advantages 
of PDMS mentioned above, the microfluidic devices in this dissertation were made of 
PDMS. 
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Because of the advantages of this technology, microfluidics has revolutionized the 
analysis of small amounts of samples and has been adapted for characterizing the 
contents of single cells
12, 13
 and single molecules
14-16
. Particularly, microfluidic systems 
have already been broadly used in the field of neuroscience, the applications including 
separation and sensing of neurotransmitters
17
, guidance of neuronal growth
18
, isolation of 
axons and somata for manipulation of subcellular regions
19, 20
, and studies of neuron-
neuron
21
 and neuron-glia cells interactions
22
. A neuron culture platform made of 
extracted PDMS has also been developed for culturing neurons at low densities
23
. 
 
1.3 Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry 
(MALDI-TOF MS) and MALDI Imaging 
 Mass spectrometry (MS), by definition, is a technique that measures the mass-to-
charge ratio (m/z) of charged particles. As a detection method, it can provide high 
information content, including the molecular weight and the chemical structure of 
analytes. A typical MS instrument mainly consists of an ionization source, a mass 
analyzer, and a detector.
24
 In the ionization source, molecules of interest are vaporized 
and ionized, which are then introduced into the mass analyzer that separates different ions 
according to m/z. Usually the detector is an electron multiplier that converts the event of 
ion incidence into a cascade of electrons. A computer records these signals and generates 
a mass spectrum of peak intensity versus m/z. The whole system is maintained in a high 
vacuum (10
-6
 to 10
-8
 torr) to allow the free movement of the ions in the instrument 
without collision with other particles.
25
 There are various ionization methods and mass 
analyzers available for specific applications. Nowadays MS has become the technology 
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of choice for proteomics and peptidomics studies, particularly since the advent of soft 
ionization methods including matrix-assisted laser desorption/ionization (MALDI)
26
 and 
electrospray ionization (ESI)
27, 28
.  
 The specific instrument used in this dissertation is the combination of MALDI 
and a time of flight (TOF) analyzer. With MALDI, the sample is co-crystalized with and 
embedded into a large excessive amount of a UV-absorbing material, named as matrix, 
on a steel or gold target plate. The matrix is usually a small organic acid, such as 2,5-
dihydroxybenzoic acid (DHB), α-cyano-4-hydroxycinnamic acid (alpha-cyano), and 3,5-
dimethoxy-4-hydroxycinnamic acid (sinapinic acid). A laser, typically a pulsed nitrogen 
laser beam (wavelength: 337 nm), is used to illuminate the crystals on the plate, 
desorbing and ionizing the matrix molecules from the surface. The charged matrix 
transfers the energy and protons to the analyte molecules so that the analytes also become 
charged in the gas phase. Because the matrix material absorbs the majority of laser 
energy, MALDI provides a soft ionization method for studying fragile biopolymers, such 
as peptides and proteins.
25
 
 The pulsed nature of generated ions in MALDI makes it well compatible to the 
TOF mass analyzer which is in a form of a long tube. In TOF, ions are accelerated with a 
high potential (25 kV in this research) into the drift tube. Because of the same 
accelerating potential, ions with the same charge possess the same kinetic energy
25
: 
zUmvKE  2
2
1
                                                                                                           (1.5) 
where KE, m, v, and z represent the kinetic energy, mass, velocity, charge of the ions 
respectively, and U is the accelerating potential. In a tube of length L, the time of flight of 
an ion in the tube, t, is related to its mass-to-charge ratio (m/z) by
25
: 
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2
22
L
Ut
z
m
                                                                                                                        (1.6) 
Therefore, the ions with larger m/z travel slower in the tube and need more time to reach 
the detector. The computer can record the time and convert it into m/z according to the 
equation (1.6).  
 In reality, the ions formed in the MALDI source have varied initial kinetic energy. 
To compensate the spread of initial energy, an extraction delay (80 ns in this study) 
before ion acceleration is applied. In this way, ions with higher initial kinetic energy 
moves deeper into the voltage field and thus experience a slightly lower accelerating 
voltage.
29
 To further reduce the spread and increase the mass resolution, an ion mirror, 
named as reflectron (a voltage of 26.5 kV in this study), is installed at the end of the TOF 
tube. With the reflectron, charged particles are reflected back to the detector. The ions of 
the same m/z but with higher velocity due to the initial kinetic energy penetrate the 
electrical field of the reflectron further and thus spend more time on reflection, giving the 
ions with lower velocity the opportunity to catch up.
24
 The whole process of MALDI-
TOF MS is depicted in Fig. 1.1.  
 MALDI mainly produces singly-charged ions, therefore generating mass spectra 
relatively simple to interpret.
25
 It has a low detection limit, able to detect femtomole 
peptides routinely.
24
 In addition, MALDI-TOF can analyze a large mass range up to 
300,000 Da.
30
 Compared to ESI, MALDI has a higher tolerance towards salts and 
contaminants and has a lower degree of ion suppression. Because of these advantages, 
MALDI has been widely used for proteomics and peptidomics studies, including 
investigations of nervous tissues from different animals
31-34
. On the other hand, MALDI 
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has its limitations, including that the detection of analytes with mass less than 1000 Da is 
interfered with matrix peaks and that MALDI is not quantitative
35, 36
.   
 One of the most important advancements of MALDI-MS is the development of 
MALDI-based MS imaging.
37, 38
 MALDI imaging adds the spatial information to 
characterization by visualizing the distribution of biomolecules, such as peptides, proteins, 
and metabolites, within a thin slice of sample. To obtain a MALDI image, typically a 
tissue slice is fixed onto a microscope slide, and a layer of matrix is applied onto the slice. 
The slide with the sample is then introduced into the MALDI mass spectrometer that can 
scan the surface of the slide and collect the mass spectrum at each spot. Imaging 
processing software can then create MS images of analyte distribution from the huge 
dataset and register the MS images to the optical microscopic images.
37
 MALDI imaging 
does not require prior knowledge of the location and identity of analytes, allowing areas 
containing the specific or unexpected molecules to be discovered. With MALDI imaging, 
two-dimensional
39
 and even three dimensional
40
 maps of analytes can be constructed, 
providing new insights into biological processes in a tissue sample
41
.  
  
1.4 Interfacing Microfluidic Devices with MS 
 As shown above, microfluidic devices are well suited for sampling and 
manipulating mass-limited samples; MS can provide detailed information of the analytes 
of interest. To fully take advantage of these two techniques, it is important to have an 
efficient interface between the microchip and the mass spectrometer. ESI and MALDI are 
the two most widely used ionization methods for analysis of biomolecules such as 
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proteins and peptides. Here we present a short review on the existing technologies that 
have been developed to couple microfluidics to each of the ionization methods. 
 
1.4.1 ESI Interfaces 
 In contrast to MALDI, ESI is primarily used for liquid samples. In ESI, the 
sample is introduced to a capillary needle maintained at a high voltage, where a Taylor 
cone forms and an aerosol of charged droplets is emitted. With the evaporation of 
solvents assisted by blowing nitrogen and heat, the charged droplets finally turn into gas-
phase ions in a process called Coulombic explosion.
30, 42
 The ions formed in ESI usually 
carry multiple charges. The nature of the ionization process makes ESI-MS readily 
capable of being coupled with microfluidic devices in an online mode. The interfaces can 
be fabricated in various ways, in which the liquid is directly sprayed from the chip, a 
capillary is attached to the end of the channel, or the spray emitter is fabricated as a part 
of the chip.
43, 44
  
 In the direct spraying approach, the liquid is sprayed from the open end of a 
microchannel at a high voltage.
45, 46
 The flow can be driven either by pressure
45
 or an 
electrical field
46
. The early devices were made of glass, whose hydrophilic property 
causes the spreading of liquid around the open outlet on the planar edge of the chip, 
leading to a large dead volume of the spray and reduced separation resolution.
47
 To 
reduce the liquid spreading, the channel outlet was coated with hydrophobic materials 
such as alkylsilanes.
45
 Alternatively, the devices can be made of hydrophobic polymers, 
such as PDMS
48
 or polyethylenerephthalate (PET)
47
. Porous monolith materials
49
 and 
hydrophobic membranes
50
 can also be integrated to the exit, resulting in a more stable 
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spray. However, because of the planar edge, it is difficult to always form the Taylor cone 
exactly at the position of the channel outlet.
47
 Thus the direct spraying method provides a 
simple interface between the microfluidic chip and the mass spectrometer, with the cost 
of performance.  
 A more sophisticated interface is made by attaching an electrospray capillary to 
the channel. In an early example, a fused silica capillary was glued to the end of a 
microchannel and the flow was driven by electroosmotic pumping.
51
 With the protruding 
capillary, the place where the spraying occurred was well defined and the voltage was 
relatively easily applied at the capillary. A limit of detection in the low fmol/μL range for 
peptide standards was achieved. However, the alignment was a difficult task and a 
relatively large dead volume existed in the chip-to-capillary interface. The glues used in 
the interface could be dissolved in some organic solvents and thus interfere with the 
sample signals. Alternatively, a liquid junction was integrated into the chip to couple the 
microfluidic device with removable ESI capillary tips.
52-54
 This configuration did not 
require glues and allowed easy substitution of either the microdevice or the capillary if 
needed. A low dead volume connection between the chip and the capillary was achieved 
by a drilling process into the edge of the device with 200-μm tungsten carbide bits.55 The 
standard pointed drill bits created a conical shaped-geometry at the end, forming a dead 
volume of 0.7 nL at the junction when a capillary was inserted into the hole. The dead 
volume was eliminated effectively by drilling the chip with a flat-tipped bit. However 
effective, the drilling process is labor-intensive and requires manual implementation, not 
amenable to automation required by commercial production.  
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 On-chip integrated emitters can essentially overcome the challenge of dead 
volume associated with coupling the channel with the external emitter, so that the 
separation efficiency will not be compromised. Fabrication of integrated spray tips on the 
microchips has been realized in hard materials like silicon
56, 57
 and glass
58, 59
, as well as 
various polymer materials, such as PDMS
60, 61
, poly(methyl methacrylate) (PMMA)
62
, 
and polycarbonate (PC)
63
. With the excellent fabrication properties of silicon, sharp 
emitter tips can be made both in the plane
56, 57
 and out of the plane
64, 65
 of silicon wafers, 
by using wet etching or deep reactive ion etching. The emitter array was also fabricated 
in a single silicon chip, enabling high-throughput analysis.
56, 65
 For example, the ESI chip, 
which contains an array of out-of-plane electrospray nozzles and can be coupled to an 
automated sample delivery system, is already commercialized (by Advion).
64, 66
 This chip 
achieved a high nozzle-to-nozzle reproducibility. But silicon chips can not always be 
applicable, especially when a high voltage is needed on the chip, such as in 
electrophoretic separation. In these situations, the use of glass or polymer chips is 
necessary instead of silicon. For glass emitters, the tips can be made by milling at the end 
of a microchannel
58
, or by patterning a microchannel in such a way that the outlet is 
directed to a rectangular corner of the chip
59
. However, the processing of glass is 
relatively slow and tedious. Compared to glass, fabrication with polymers is quicker and 
simpler. The emitters on a PDMS chip are typically made by cast molding, which are 
able to produce a stable spray.
61, 67
 But PDMS is not compatible to many organic solvents, 
limiting its use for broader applications. Sharp emitter tips can also be fabricated with 
micromachining on other materials, for example, out-of-plane emitters were made by 
micromilling of PMMA
62
 and laser ablation of PC
63
. With the PMMA emitters, detection 
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limits of 10
-8
 mol/L were achieved for standard peptides.
62
 In-plane emitter tips can also 
be made by micromachining.
68, 69
 The commercially available Agilent high performance 
liquid chromatography (HPLC)-Chip contains polyimide separation channels, and an in-
plane electrospray tip made by laser ablation of the polyimide.
68
 The sensitivity of the 
HPLC-Chip was archived to be five times that of the conventional nano LC-MS. An 
alternative way to make a sharp tip at the channel outlet is to manually cut the polymer.
60, 
70
 Despite of the poor reproducibility, this manual cutting method is very simple to 
perform and has been used for fabricating emitter tips and tip arrays on PDMS
60
, 
PMMA
70
, polyimide
71
, and so on. The most accurate and reproducible method for 
fabricating sharp emitter structures has been achieved with photolithography on devices 
made of the photoresist SU-8
72, 73
 or parylene
74
. For the SU-8 emitters, a relative standard 
deviation of 14% was achieved between different nozzles.
73
 The procedure of 
photolithography also permits the mass production of accurately-defined emitter tips. 
 
1.4.2 MALDI Interfaces 
 As another commonly used ionization method, MALDI analyzes samples 
crystallized on a target plate. Therefore, the most straightforward way for interfacing 
microfluidic chips with MALDI is through offline coupling. The offline interfaces can be 
divided into two categories: deposition of eluents from the microfluidic device onto a 
standard target plate, and direct use of the microfluidic substrate as the MALDI target. 
Meanwhile, online coupling is also possible with a suitable design of the interface that 
enables the continuous delivery of samples into the mass spectrometer for real-time 
detection.
75, 76
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1.4.2.1 Offline Interface to MALDI by Deposition 
 The simplest approach to deposit samples from the microchannel is direct 
spotting.
77, 78
 In one example, a PMMA microfluidic chip that performed enzymatic 
digestion of proteins was mounted in a MALDI spotter. A fused silica capillary was 
attached to the channel outlet on the chip, where the sample was mixed with the matrix 
introduced from a coaxial tube. The mixture was then directly spotted onto a target plate. 
A high sequence coverage of protein standards was achieved by this system.
78
 However, 
with mechanical spotting alone, it is difficult to precisely control the volume of liquid to 
be spotted and the action of spotting may disturb the flow inside the microchannel. To 
overcome these challenges, samples are deposited onto the MALDI target by a 
piezoelectric dispenser instead.
79, 80
 For example, a microdispenser was used to quickly 
deposit droplets of protein digestion products from a microfluidic device to a high-
density array of nanovials on a silicon target plate.
79
 With this method, the volume of the 
droplet to be spotted can be well defined.   
 Alternatively, electrospray can be used to deposit the sample from a chip, 
resulting in a more uniform sample film on the surface.
50, 81
 In one electrospray 
deposition system, a polytetrafluoroethylene (PTFE) membrane was bonded onto the 
outlet of a PC microfluidic chip to form a hydrophobic electrospray tip. The gap between 
the tip and the target plate was maintained at 500 μm to 1mm. A syringe pump was used 
to generate the flow in the channel and a high voltage was applied to the T-junction to 
introduce electrospray. A detection limit of 3.5 fmol was achieved for a standard peptide, 
angiotensin II, with this system. An array of three electrospray tips with 150 μm apart 
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from each other was successfully used for parallel deposition of different analytes 
without cross-contamination of samples from adjacent spots.
81
  
1.4.2.2 Offline Interface to MALDI by Using the Microfluidic Chip as the Target 
 The substrate used in a microfluidic device is typically flat, allowing it to be 
directly used as a MALDI target. Compared to the offline deposition described in the 
previous section, this approach eliminates the deposition step and the need of spotting 
instruments.  
 The open channel configuration is one of the ways to make the chip accessible by 
MALDI characterization.
82, 83
 In a simple design of rapid open-access channel 
electrophoresis (ROACHE)
82
, electrophoretic separation was performed in an open 
microchannel for a certain time before the sample was eluted out of the channel. A matrix 
was added into the sample before separation. After the solvent in the channel was 
evaporated, the sample became cocrystallized with the matrix. The chip was then loaded 
into the MALDI spectrometer to generate a spatial map of separated analytes in the 
channel area. MALDI has also been interfaced to the on-chip capillary isoelectric 
focusing (CIEF) in a similar manner.
83
 In CIEF, molecules are separated according to 
their specific isoelectric points. After the separation was completed, a matrix solution was 
applied onto the chip surface with electrospray for subsequent MALDI imaging. To 
prevent the solvent evaporation during separation, a pseudo-closed microchannel design 
was used, which consisted of a base chip and a cover chip, both made of PMMA.
84
 The 
channel features were fabricated in the base chip. During separation, the cover chip was 
placed on top of the base to form sealed channels. After the completion of separation, the 
cover was removed to allow the access to the channel area by MALDI interrogation. 
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Similarly, a resin tape was also used to temporarily cover the separation channels in a 
microfluidic device.
85
 Gel electrophoresis performed in a microfluidic device has also 
been demonstrated to be readily interfaced to MALDI.
86
 The gel electrophoresis device 
was composed of a PMMA base and a removable PDMS cover. Cross-linked gel was 
formed inside the microchannel with polymerization after assembly of the device. 
Following sample migration, the PDMS cover was peeled off and either the base or the 
cover was characterized with MALDI. In this case, the gel itself was utilized as the 
matrix and infrared laser was used to enable deeper penetration into the gel. 
 Besides electrophoresis, the microfluidic devices performing other sample 
preparation processes can also be directly interfaced to MALDI. For example, a PDMS 
device was developed to conduct multiple enzyme assays simultaneously on the peptides 
deposited on the substrate; the substrate was then used as a target for MALDI 
characterization.
87
 More specifically, in this device the substrate of gold was coated with 
a self-assembled monolayer of alkanethiolate with an end maleimide group designed to 
adhere peptide molecules. A piece of PDMS with parallel channels was placed on top of 
the substrate and the different cysteine-terminated peptide solutions were flown through 
each of the channels, during which the peptides were immobilized onto the surface. The 
PDMS piece was removed from the substrate, and then was rotated in 90° and reapplied. 
The channels were then infused with various enzyme solutions; in this configuration, 
each enzyme was allowed to interact with the whole set of the deposited peptides. After 
that, the PDMS was removed again and the interaction regions of enzymes and peptides 
were analyzed with MALDI-MS. This system offers the capability for high-throughput 
analysis of enzyme reactions.  
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 A compact disk (CD) microfluidic device that allows the direct application of 
MALDI-MS within the chip has been commercialized (from Gyro AB).
88
 Multiple 
microstructures can be fabricated onto the disk, for instance, microcolumns packed with 
C18 beads are made in the radial direction. After the CD starts to rotate, the centrifugal 
force pushes the sample in each structure through the column; the sample is retained by 
the C18 beads but the salts and impurities are drawn into the waste. A matrix solution is 
then used to elute the sample from the column and the sample is collected onto a gold-
coated region, which is to be interrogated with MALDI. The CD chips have been 
successfully used for parallel analysis of in-gel digestion products of proteins and for 
enrichment of phosphopeptides.
89, 90
 
1.4.2.3 Online Interface to MALDI 
 With special designs, the microfluidic devices can also be interfaced to MADLI in 
an online mode. One innovative approach for online interface utilizes the vacuum in the 
ionization source of the mass spectrometer to continuously pull the solution through the 
channel.
91, 92
 In one microfluidic device, a glass cover contained two sample loading 
channels that converged into one reaction channel. The glass cover was then bonded onto 
a silicon wafer to seal the channels, and the entire device was mounted onto a modified 
MALDI target. The two inlet reservoirs were filled with reactant solutions and then 
sealed, meanwhile the outlet remained open. After the target was introduced into the 
vacuum of MALDI, the pressure difference between the inlet and the outlet drew the two 
reactant solutions into the reaction channel where they were mixed and reacted with each 
other. The products with any unreacted reactants were dried at the outlet reservoir, which 
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could be accessed by the MALDI laser. In this way, a chemical reaction can be monitored 
continuously.
91
 
    Besides the vacuum approach, online coupling of microfluidics with MALDI 
has also been realized with mechanical designs that can continuously deliver the analytes 
at the atmosphere into the vacuum chamber without breaking the vacuum.
93-96
 An 
interesting example is to use a rotating ball. In this example, a PMMA chip was 
micromilled to have a V shape at the channel exit. The V tip was in contact with a 
rotating ball; one half of the ball was exposed to the atmosphere while the other was in 
the vacuum of the mass spectrometer. The eluent from the channel was deposited onto 
the ball while the matrix was supplied by another capillary. As the ball rotated, the 
eluent/matrix mixture was then introduced into the vacuum for MALDI analysis. This 
cycle of deposition and ionization was repeated so that a continuous delivery of the 
sample into MALDI was achieved.
95
 
 In the microfluidic systems presented in this dissertation, we used the offline 
interface by collecting the neuropeptides onto a derivatized substrate, which was then 
directly used as a target plate for MALDI imaging analysis. Such an interface, as 
mentioned before, is simple to operate and does not require any special instrument. The 
imaging capability of MALDI allows the analytes, expected or unexpected, to be 
identified on the surface without the need to know their exact locations in advance. 
 
1.5 Dissertation Overview 
 This dissertation demonstrates several PDMS microfluidic chips that can control 
and sample the microenvironments of the small areas around neurons. With a suitable 
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sample collection method, neuropeptide release from neurons of the model system, 
Aplysia, can be investigated with a temporal and spatial resolution, down to single cell 
sampling. 
 In Chapter 2
97
, a sampling method by functionalizing a silicon or glass surface 
with a self-assembled monolayer of octadecyl alkyl chains (C18) is demonstrated. 
Comparing to other surfaces modified with different reagents, C18 was shown to be the 
optimal and the most universal way to collect peptides. A PDMS microfluidic device 
containing an octadecyltrichlorosilane (OTS)-derivatized silicon substrate was developed 
for temporal analysis of peptide release from a small number of neurons. The design 
consists of a reservoir for placing cells, and three branching channels that can sample the 
environment in the reservoir before, during, and after neuronal stimulation. Multiple 
released peptides were detected only in the middle channel and they were separated as in 
thin layer chromatography. This chapter also describes a modified microfluidic device 
that has a single neuron loaded into the channel and a functionalized glass substrate to 
facilitate microscope monitoring. The results indicate that the microfluidics is well suited 
for single cell measurements. In addition, the surface coverage of various peptides was 
studied with scintillation measurements of radiolabeled peptides adsorbed onto substrates 
as well as by flowing increasing amounts of standard peptides through a microfluidic 
device with a serpentine channel. The results from the serpentine channel show the 
potential to use adsorption length to quantify the amount of a peptide, which is the focus 
of the next chapter. 
 Chapter 3
98
 describes a novel method to quantify peptide release from a small 
number of neurons by measuring the adsorption length of each peptide. The PDMS 
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microfluidic device used here is an enhancement to the device with a serpentine channel 
shown in Chapter 2. Flow rate in the new device can be precisely controlled with a 
syringe pump. The silicon substrate is patterned with OTS and oligo(ethylene glycol) that 
significantly reduces the loss of peptides to the reservoir area. The PDMS surface is also 
modified with oligo(ethylene glycol) to reduce the absorption of analytes into PDMS, the 
effectiveness of which was demonstrated by scintillation measurements of peptide 
recovery from incubation with PDMS treated with different protocols. A simplified 
mathematical model supports the concept of quantitation based on adsorption length and 
separation of multiple peptides according to the adsorption capability. The calibration 
experiments on a single peptide, acidic peptide, demonstrate the expected linear 
relationship between length and amount. The experiments on multiple peptides, acidic 
peptide and α-bag cell peptide, show that the two peptides are separated and that the 
length-to-amount relationship for individual peptide remains to be linear. The variance of 
length measurements between devices is as low as 3%. By applying this quantitation 
approach on Aplysia bag cell neurons stimulated with elevated potassium, the measured 
peptide amounts are comparable to the measures using other methods. Our method based 
on adsorption length provides a simple, label-free, and robust way for quantifying small 
amounts of samples within microfluidic devices. 
 To add a spatial resolution to peptide release studies, Chapter 4 demonstrates a 
compartmentalized microfluidic device that can separate the cell body (soma) of a neuron 
from its processes. The device contains one main channel and two secondary channels; 
they were connected with a number of small interconnects. Glass coverslips were used as 
the substrates to permit continuous monitoring of cells inside the microchannel with 
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optical microscopy. Under appropriate conditions, the process growth from neurons 
loaded into the main channel can potentially penetrate the interconnects into the adjacent 
secondary channels. The high resistance of interconnects, combined with hydrostatic 
pressure manipulation, allows the flow in each channel to be separately controlled. Using 
a pipette to pull the cell solution through the channel was demonstrated to be the most 
effective way for loading cells into the microchannel. Neuron viability in the 
microchannel was increased by introducing a perfusion flow in the system and by serial 
solvent extraction of PDMS to remove toxic materials in the cured polymer. The glass 
surface is patterned with repeated lines of poly-L-lysine (PLL) and bovine serum albumin 
(BSA) to guide the direction of process growth. 
 Chapter 5 concludes the previous chapters and describes the future directions of 
this research project. One area for future endeavor is to continue working on the 
compartmentalized microfluidic device by applying the PLL/BSA patterning to cell 
culturing in the device to guide the neurites through the interconnects and by combining 
the OTS collection method with this device to sample local peptide release from 
subcellular regions of individual neurons. Microfluidic devices that can compare the 
components and quantities of released peptides under different physiological conditions 
are to be developed. Moreover, to gain insights into important chemical signals during 
neuronal network formation, the development of microfluidic systems that allow 
neuronal wiring within the device and collection of local microenvironment during this 
event is an important area to be explored in the future.  
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1.6 Figures 
 
 
 
Figure 1.1 Schematics of MALDI-TOF MS. In the MALDI ionization source, the analyte 
molecules are embedded into a UV absorbing material, matrix. A laser beam desorbs and 
ionizes the matrix and analyte molecules, and the charged particles are pushed into a TOF 
mass analyzer by an electrical field. The mass analyzer is a long drift tube, in which ions 
with higher m/z travel slower. An ion mirror, reflectron, is installed at the end of the tube 
to reflect the ions back. Because of the difference in flight velocity, ions with increasing 
m/z reach the detector sequentially. A computer records the signals and converts the time 
of flight into m/z, generating a mass spectrum we can read. MALDI: matrix-assisted laser 
desorption/ionization, TOF: time of flight, m/z: mass-to-charge ratio, and v: velocity. 
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CHAPTER 2 
 
MASS SPECTROMETRIC IMAGING OF PEPTIDE RELEASE FROM 
NEURONAL CELLS WITHIN MICROFLUIDIC DEVICES 
 
 
2.1 Notes and Acknowledgements 
 This chapter was modified from a manuscript published in Lab on a Chip in 2007 
(DOI: 10.1039/B706940E. Kyubong Jo, Michael L. Heien, Lucas B. Thompson, Ming 
Zhong, Ralph G. Nuzzo and Jonathan V. Sweedler, “Mass spectrometric imaging of 
peptide release from neuronal cells within microfluidic devices,” Lab Chip, 2007, 7, 
1454-1460. http://pubs.rsc.org/en/Content/ArticleLanding/2007/LC/b706940e. 
Reproduced by permission of The Royal Society of Chemistry.)  This work focused on 
interfacing microfluidics and mass spectrometry imaging to interrogate peptides released 
from neuronal cells.  Several device formats were developed for this purpose.  In this 
work, Dr. Kyubong Jo performed the experiments on sampling efficiency from the 
octadecyltrichlorosilane (OTS)-modified surface, surface coverage of angiotensin II by 
using a microfluidic device with a serpentine channel, and neuropeptide release by using 
a device with three branching channels.  Dr. Michael L. Heien and Dr. Lucas B. 
Thompson meaured surface coverage using radioisotope labeled molecules and 
conducted single cell analysis.  I applied the serpentine channel design to another peptide, 
substance P, and compared the OTS surface with other modified surfaces in terms of 
sampling efficiency.  The work is reproduced here for completeness.  This study was 
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supported by the W.M. Keck Foundation and the National Science Foundation through 
Awards CHE-05-26692 and CHE-04-02420.   
 
2.2 Introduction 
Microfluidics offer promise as a revolutionary technology in analytical 
chemistry.
1
  Microfluidic technology provides advantages such as small reaction 
volumes, minimal reagent consumption, portability, disposability, and local control of the 
microenvironment.  These advantages directly contribute to enhancing analytical 
performance in a number of applications.  Moreover, integrated components facilitate a 
variety of functions such as sample clean-up, concentration, separation, and detection.
2
  
As a result, microfluidics have revolutionized the analysis of small amounts of analytes 
and have been adapted for characterizing the contents of  single cells
3, 4
 and single 
molecules.
5-8
  
For microfluidic applications, analyte detection remains an important issue given 
the small sample-volumes typically available.  Accordingly, many analyses have been 
conducted using laser-induced fluorescence, by which small sample-volumes are easily 
probed with unparalleled mass detection limits.
9-11
  Even single molecules have been 
effectively analyzed using fluorescence techniques in microfluidic devices.
5-8
 
Fluorescence imaging (microscopy) is particularly beneficial because large areas 
of the device can be probed, and the field of view of many microscopes matches typical 
microfluidic device dimensions.  Because of the ease of adapting fluorescence imaging to 
such devices, and its high sensitivity, it is among the most commonly employed detection 
schemes for microfluidics.  Although fluorescent technology has many advantages, it is 
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limited to analyzing previously labeled target molecules or those that have specific 
reactive groups, and can be difficult to adapt when characterizing unknown molecules.  
Mass spectrometry (MS), on the other hand, offers unparalleled information 
content.  The high sensitivity of MS is an essential component for the identification of 
low-abundance species from mass-limited samples.  The integration of microfluidic 
systems with MS has received substantial attention following early demonstrations of 
microfluidic electrospray (ESI)-MS interfaces.
12, 13
  On-line ESI-MS offers a simple 
approach for directly interfacing the mass spectrometer to a microfluidic device.  These 
systems allow reproducible quantitation with high sensitivity, and are now commercially 
available.
14
  As opposed to on-line ESI-MS, matrix-assisted laser desorption/ionization 
(MALDI)-MS  can measure the eluant from a microdevice with off-line coupling.
15
  This 
off-line approach offers the advantages of parallel sample deposition and on-chip sample 
processing such as sample desalting prior to MS analysis.  As an alternative to off-line 
coupling, a section of the microfluidic device can also be utilized as the MALDI target.  
For example, open-top microchannels have been used as MALDI targets to analyze 
molecules that are dried after electrophoresis or isoelectric focusing.
16, 17
  In another 
recent study, an alkane-thiol coated gold surface was used as a MALDI target after 
parallel enzyme reactions within a microfluidic network.
18
 
One of the most intriguing recent advances in MALDI-MS has been the 
development of MALDI-based mass spectrometric imaging (MSI).
19-21
  Building upon 
the early application of MALDI-MS to create molecular images from a variety of 
surfaces,
21-23
 MSI has been used to measure the distribution of biomolecules in tissue 
sections.
19-21
  Two-dimensional, or sometimes three-dimensional,
24
 intensity maps have 
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been reconstructed to create molecular images; these images provide molecular 
information with relative abundance and spatial distribution, allowing for better 
understanding of the biological processes in a tissue sample.
25
  Although microfluidic 
devices are amenable to MALDI-MSI, to the best of our knowledge, molecular imaging 
has not been demonstrated from a microfluidic device.  Imaging of the compounds from a 
functionalized surface coupled to a microfluidic device yields a wealth of information 
concerning the detailed spatial arrangement of analytes within that device.  In many 
ways, the advantages of this approach may mimic the benefits of using fluorescence 
microscopy from microfluidic devices as opposed to single-point fluorescence detection.  
In other words, by probing a device with MSI, areas of interest that contain specific 
analytes or unexpected compounds can be discovered, even if the precise location is not 
known in advance. 
 Here we present an approach whereby we interface microfluidics with MSI.  The 
goal is to create a system that allows neurons to be stimulated and neuronal release to be 
collected and monitored.  Several elegant chip-based designs for characterizing peptide 
secretion have appeared that use laser-based fluorescence detection.
26, 27
  Peptide 
profiling of neurons has often used MS due to the sensitivity and structural information 
that can be acquired.
28, 29
  Our goal here is to develop microfluidic devices that can be 
used to manipulate the extracellular environment of neurons, collect the resulting 
neuropeptide release, and examine the releasate with spatial, temporal and chemically 
selective analyses.  We demonstrate this approach by analyzing peptide release using 
Aplysia bag cell neurons as a model.  Aplysia is a well-known neurobiological model 
with a well-characterized physiology and biochemistry;
30, 31
 the bag cell neurons are ideal 
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for validating the measurements because of their equally well-known neuropeptide 
complement.
32, 33
 
 
2.3 Experimental 
Appendix A contains a master list of all abbreviations used in this chapter. 
2.3.1 Materials and Reagents 
Unless noted, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO) 
and used as received.  Silicon wafers were from Montco Silicon Technologies, Inc 
(Royersford, PA).  Photoresist SU-8 100 and SU-8 2010, and developer were obtained 
from MicroChem Corp. (Newton, MA).  Glass coverslips (24 × 60 mm No. 1 thickness) 
were obtained from Fisher Scientific (Pittsburgh, PA).  Radiolabeled [
14
C] cytochrome c 
was obtained from American Radiolabeled Chemicals Inc. (St. Louis, MO).  Artificial 
seawater (ASW), pH 7.8 (460 mM NaCl, 10 mM KCl, 10 mM CaCl2, 22 mM MgCl2, 6 
mM MgSO4, 10 mM HEPES) was used in all experiments involving Aplysia.  
 
2.3.2 Device Fabrication 
Microfluidic devices were formed by molding poly(dimethylsiloxane) (PDMS), 
Sylgard 184, (Dow Corning, Midland, MI) onto a photolithographic master as described 
previously.
34, 35
  Briefly, negative SU-8 photoresist was used to fabricate a master by 
exposure through a pattern mask.  Small pieces of tubing were glued to the master prior 
to pouring PDMS over the master.  PDMS devices were cured at 65 °C for several hours 
and removed from the master.  The tubing pieces were pulled from the PDMS creating 
voids where the full-length tubing was inserted.  For a reservoir, a hole was punched at 
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the inlet using a 5-mm-diameter biopsy punch, or a piece of wide tubing (2 mm outer 
diameter) was used as a mold to create the reservoir.  The fabrication procedure is 
illustrated in Fig. 2.1.  
  
2.3.3 Surface Derivatization 
Silicon surfaces were derivatized with octadecyltrichlorosilane (OTS) in organic 
solvent.
36
  A wafer was dipped in a 100 mL solution of chloroform (30 mL) and hexane 
(70 mL) containing OTS (0.8 % v/v) for 5 min and then transferred to hexane solution for 
10 min.  A derivatized silicon wafer was washed with acetone and dried at 65 °C for at 
least 6 h.  To test if OTS offers optimal ability of collecting peptides, silicon wafers were 
also treated with (N,N-Dimethylaminopropyl)trimethoxysilane (DMAPTS), (3-
aminopropyl)trimethoxysilane (APTS), and dimethyloctadecyl[3-
(trimethoxysilyl)propyl]ammonium chloride (DMOPAC) for comparison.  The 
derivatization process and condition of DMAPTS and APTS is the same as OTS.  While 
DMOPAC was dissolved in DI water (0.1% v/v) and the silicon wafer was dipped into 
the solution for 5 min.  The substrate was then rinsed with DI water to remove excess 
DMOPAC and dried with nitrogen.  The derivatized wafer was cured at 110 °C for 1 h.  
Before use, surfaces were rinsed with methanol and water.  For cell plating, a droplet (1 
μL, ~1–2 mm diameter) of 1% poly-L-lysine solution was placed and dried on the 
functionalized surface.  A reservoir in a PDMS device was aligned with the poly-L-lysine 
coated area. 
Alternatively, octadecanethiol (C18) derivatized gold strips were fabricated on 
glass coverslips.
37
  For this derivatization, glass coverslips were cleaned in piranha 
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solution (Caution! Piranha is a strong oxidant.  It may explode on contact with organic 
residues), rinsed, and dried with N2.  PDMS was then conformally sealed to the 
coverslips to create a stencil mask for the subsequent deposition of gold using a 
Temescal FC-1800 e-beam evaporator.  The coverslips with the deposited gold were 
then immersed into a 2% v/v solution of octadecanethiol in ethanol for 30 min, and then 
rinsed with ethanol and water.  The coating of poly-L-lysine was done by applying poly-
L-lysine to the glass slide prior to sealing with the channel.  The poly-L-lysine solution 
was placed on the glass surface for ~1 h. 
 
2.3.4 Biological Experiments 
Aplysia californica (100–300 g) were supplied by Vivida Biological (Santa 
Barbara, CA) and kept in a tank with aerated and circulated seawater at 14 °C.  For 
dissection, animals were anesthetized by injection of isotonic magnesium chloride 
solution (~30 to 50% of body weight) into the body cavity.  Individual Aplysia bag cells 
were isolated after incubation in ASW with proteases (1% type IX and 1% type XIV, 
Sigma-Aldrich) at 35 °C for between 60–120 min as described previously.38, 39  The cells 
were then transferred onto a poly-L-lysine coated area on the surface in a microfluidic 
device.  For the potassium stimulation experiments, elevated potassium chloride solution 
(final concentration 60 mM) was added to stimulate neurons to release peptides, which 
were transported and collected on an OTS coated surface.  Fig. 2.2 shows an overview of 
these procedures. 
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2.3.5 Mass Spectrometric Imaging 
After completing the biological experiments, as much solution was removed from 
the device as feasible, and the PDMS device was peeled off from the surface.  The 
surface was briefly washed with DI water to remove salts from the cell media.  MALDI 
matrix was applied to surfaces using a commercial airbrush (Badger, Franklin Park, IL).
40
  
The airbrush nozzle was positioned at a distance of ~10 cm from the surface, and 2,5-
dihydroxybenzoic acid (10 mg/mL in acetone) was sprayed onto the surface. 
MALDI-MS detection was performed with a Bruker Ultraflex II mass 
spectrometer (Bruker Daltonics Inc., Billerica, MA) with a solid-state UV laser. Mass 
spectra were obtained as sums of 100 laser shots at 50 Hz in the reflectron mode with an 
acceleration voltage of +25 kV.  Imaging resolution ranged from 100 μm to 200 μm.  All 
mass spectra were externally calibrated and MS image analysis was performed with 
Bruker FlexImaging, Biomap imaging software (http://www.maldi-msi.org/), and 
homemade software written in Microsoft Visual C# 2005, Express Edition 
(http://www.microsoft.com).  
 
2.3.6 Surface Coverage Measurement Using Radioisotope Labeled Molecules 
The quantity of radiolabeled molecules was measured by using a phosphorimager 
as described previously.
41
  Briefly, radioactive stock solution was diluted with ASW to a 
volume of 86 µL, giving a final concentration of 2 µM.  The samples were covered with 
Reynolds Film 910 (Grottoes, VA) and placed face down on a Fuji BAS III imaging plate 
(48-h exposure).  The decay intensities from individual channels were summed and 
background-subtracted with a Fujix BAS 1000 phosphorimager (Fuji Photo Film Co. 
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Tokyo, Japan).  The radioactivity for each spot corresponds to the image intensity, and 
was converted to a mass by comparison with intensity values acquired from a calibration 
strip. 
 
2.4 Results and Discussion 
2.4.1 Sampling from a Functionalized Surface 
We previously reported monitoring peptide release from the nervous system by 
using single-bead solid-phase extraction and MALDI-MS.
41
  Single-bead solid-phase 
extraction uses the bead surface to adsorb hydrophobic molecules to monitor peptide 
release from a neuronal sample.  The peptides are then eluted from the beads onto a 
MALDI target using the appropriate organic solvents.  This system has proven to be a 
robust sampling strategy for measuring neuropeptide release.
42, 43
   However, the 
approach requires the manual placement of the beads onto the brain slice or neuronal 
culture, followed by their removal after the neuronal stimulation; additional steps include 
a manual wash step and placement of the beads on the MALDI target. 
 Here we adapt this approach to function on flat surfaces by forming a self-
assembled monolayer of octadecyl alkyl chains.
36, 44
  This platform employs a PDMS 
microfluidic device mounted on a functionalized surface, and subsequent MS imaging for 
monitoring peptide release from the nervous system.  The surface-supported, self-
assembled octadecyl alkyl chains not only adsorb molecules through hydrophobic 
interactions, but they also allow direct MALDI-MS measurement.  Direct MS 
measurement on a flat surface facilitates MS imaging because in this two-dimensional 
plane, the positional information on the location of collected peptides is retained.  
37 
 
Advantages of this approach include the reduction of manual manipulations and ease of 
sampling the releasates.  MS imaging is an efficient way to obtain mass spectra by 
scanning the surface, which is especially useful when the exact location(s) of peptides are 
not known.  Of course, such visualization yields insights about the phenomena occurring 
within microfluidic devices such as the collection efficiency for different analytes onto 
the surfaces. 
Before applying this approach to biological measurements, we validate the 
performance of the functionalized surface for sampling peptides from the channels in 
concentrations equivalent to those previously reported in neuronal release studies from 
single, chemically stimulated neurons, (e.g., the low femtomole amount of egg laying 
hormone expected to be released from an individual Aplysia californica bag cell 
neuron).
45
  MSI of these peptides should also possess comparable sensitivity to 
conventional MALDI techniques.  Fig. 2.3 illustrates the microfluidic device used for 
sampling peptides visualized by MSI.  An OTS coated silicon surface collected four 
different standard peptides (0.5 µL of 1.0 pmol/µL), each introduced through simple 
parallel microchannels as seen in Fig. 2.3A.  The MS image shown in Fig. 2.3B depicts 
the parallel microchannel pattern of these peptides whose mass spectra are represented in 
Fig. 2.3C. 
Although glass surfaces are widely used in many biological applications,
39
 to 
ensure high-quality mass spectra are obtained, we have used silicon surfaces for these 
experiments.  The primary reason for choosing silicon is that the insulating properties of 
the glass may cause space charge effects, which can reduce the resulting signal-to-noise 
ratio (SNR).
46
  The semiconductor nature of silicon wafers avoids this charging problem.  
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We observe that low femtomole standard peptides are detected on silicon surfaces with 
high SNR, comparable to those on conventional targets.  Moreover, silicon surfaces have 
some of the same properties as glass, derivatization of silicon surfaces is common,
36
 and 
silicon has been investigated and optimized for cell biology and cell culture.
47
   
 
2.4.2 Surface Coverage 
The ability of functionalized surfaces to concentrate peptides has been 
characterized by using 
14
C-labeled cytochrome c; this radionuclide detection approach 
allows verification of performance independently from the MALDI MS performance. For 
these experiments, the PDMS channels were sealed on C18 coated surfaces to create 
separate channels measuring 200 µm × 300 µm × 1 cm.  The surfaces were activated by 
rinsing them with a 50% acetonitrile/water solution (for 30 min) prior to equilibration 
with ASW.  In order to quantitate surface coverage at low concentrations, a 1 µM 
solution of 
14
C-labeled cytochrome c was then introduced to each channel, and 1 µL of 
solution was allowed to interact with the surface.  A volumetric flow rate of 500 nL/min 
(linear flow rate = 0.014 cm/s) was used, which (on average) allows all analyte molecules 
to interact with the functionalized surface.  After the peptides were introduced, each 
channel was rinsed with 0.1 % trifluoroacetic acid to remove salts.  The PDMS channel 
system was then removed and the amount of 
14
C cytochrome c retained by the C18 
modified substrate measured.  Each channel contained 370 ± 50 fmol of material (n = 8 
channels), which corresponds to a surface coverage of 19 ± 3 pmol/cm
2
. 
In a separate experiment, the concentration of 
14
C cytochrome c was varied to 
introduce differing amounts of peptide ranging from 75–2000 fmol into the channel.  The 
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channel dimensions and flow rates are the same as those described above.  The measured 
amount of 
14
C cytochrome c on the surface in each case is given in Table 2.1.  At the 
lowest concentration tested, the entire solution was depleted over the length of the 
channel and deposited on the surface.  In addition, the high recovery rate at the lowest 
concentration implies that a major portion of the peptides were deposited on the 
functionalized surface rather than the PDMS walls. 
Although isotope labeling experiments provide quantitative surface coverage 
information, these values vary with channel dimension, flow rate, molecular weight, and 
chemical structure;
48
 for example, large hydrophilic molecules will have lower surface 
coverage than small hydrophobic molecules.  Perhaps the optimum method of measuring 
sampling efficiency is to make the measurements using the specific molecules of interest 
under identical conditions; in this case however, we do not have the appropriate 
radiolabeled peptides from Aplysia bag cell neurons.  Here we measure sample collection 
efficiency using the approach shown in Fig. 2.4 for a range of peptides.  In this method, 
molecules flow along a serpentine channel until they become depleted by interacting with 
the OTS coated surface.  As shown in Fig. 2.4, different amounts of angiotensin II (1.0 
ng, 2.5 ng and 4.0 ng) loaded in a reservoir and drawn by the negative pressure through a 
long serpentine channel are depleted at different locations along the channel: after a 
length of 12 mm for 1.0 ng, 40 mm for 2.5 ng, and 54 mm for 4.0 ng, respectively.  Given 
the 200 µm channel width, the surface coverage is 33 pmol/cm
2
 calculated from the rate 
of the increase in area covered by the peptide compared to the amount of peptide initially 
present in the solution.  The increase of adsorption length with amount was also observed 
with another standard peptide, substance P, as illustrated in Fig. 2.5.  These results imply 
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that one can estimate peptide amounts from the area on the surface covered by the 
peptide. Follow-up investigations on the quantitation of peptides based on adsorption 
length are included in Chapter 3. 
Our results show a surface coverage of 19 pmol/cm
2
 for cytochrome c (12 kDa) 
and 33 pmol/cm
2
 for angiotensin II (1046.5 Da).  Why is there a difference between the 
two?  From a simple geometrical calculation, assuming that molecules form a well-
packed square lattice monolayer, surface coverage should range from 166 pmol/cm
2
 for 
the molecules of 1 nm diameter to 7 pmol/cm
2
 for molecules of 5 nm diameter.  
Experimentally, Margel et al.
48
 reported ~17–22 pmol/cm2 for synthetic peptides 
containing multiple lysine residues and 0.4 pmol/cm
2
 for human serum albumin (65 kDa) 
on OTS coated surfaces.  Fragneto et al.
49
 reported 7.9 pmol/cm
2
 surface coverage for -
casein (24 kDa) adsorbed on OTS coated surfaces.  Our measurements are consistent both 
with geometrical considerations and prior measurements.   
 
2.4.3 Comparison of Different Derivatized Surfaces 
 Before the microfluidic system containing OTS surfaces was applied to neuron 
release experiments, we also tested if OTS offers optimal capability to adsorb peptide 
molecules compared to other derivatization reagents.  For this purpose, silicon wafers 
were treated with DMAPTS, APTS, and DMOPAC respectively.  The molecule of 
DMAPTS contains a N(CH3)2 group at the end, and APTS contains an end group of NH2. 
DMOPAC has a quaternary ammonium end group with a positively charged N and an 
octadecyl alkyl chain.  A PDMS piece with the serpentine channel was placed on top of 
each derivatized surface and 5 ng substance P was flown through the microchannel.  Fig. 
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2.6 shows the MS images from DMAPTS, APTS, and OTS surfaces. On DMAPTS, the 
peptide signals were only detected in the reservoir (Fig 2.6A).  The APTS surface 
provided better adsorption capability but still only contained sparse signal dots in both 
the reservoir and channel areas (Fig. 2.6B).  In both cases, the signal intensity was low.  
Meanwhile, OTS surface produced a continuous peptide band with strong intensity (Fig. 
2.6C).  The results here clearly demonstrate that OTS is superior to DMAPTS and APTS 
in terms of sample collection ability. 
 The surface of DMOPAC is positively charged with a long alkyl chain, therefore 
it can adsorb peptides through both electrical and hydrophobic interactions. As the 
isoelectric point (pI) of substance P is 11.5, the peptide possesses negative charge in DI 
water.  A buffer containing 0.1 M Na3PO4/Na2HPO4 (pH = 12.5) needs to be added to the 
substance P solution to convert it negatively charged.   5 ng substance P either in DI 
water or the buffer was introduced into the microfluidic device with the serpentine 
channel, and the MS imaging results are shown in Fig. 2.7.  Although it has been 
demonstrated with OTS that the hydrophobic alkyl chain can capture substance P, the 
positively charged peptide did not adsorb well on DMOPAC as no significant signals 
were observed in the channel (Fig. 2.7A).  In contrast, the negatively charged peptide in 
the buffer solution was collected on the same surface, indicated by strong peaks in the 
channel (Fig. 2.7B).  The difference in MS profiles demonstrates that electrical force 
played a stronger role than hydrophobic interaction in capturing molecules from the 
solution.  This conclusion was further supported by the fact that negatively charged acidic 
peptide (pI = 4.3) in DI water were successfully collected on DMOPAC (Fig. 2.7C).  
Charges on this surface limit its use for cell experiments, since peptide molecules 
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released by neurons can have both negative and positive charges in ASW.  Therefore, the 
OTS surface offers a more universal method for sample collection and was used for the 
following biological experiments.  
 
2.4.4 Neuropeptide Release 
Our overarching goal is to develop a platform for collecting neuropeptide 
releasates from neurons and correlate this approach with stimulation protocols along with 
temporal and chemical information.  Fig. 2.8A shows the design of a device for the 
temporal analysis of peptides released from neuronal cells mounted onto a poly-L-lysine 
coated silicon surface in an open-top reservoir.  This open-top design allows for the 
manipulation of cells as well as electrophysiological recording from those cells.  We have 
designed our initial collection system with three time-points, corresponding to before, 
during, and after chemical stimulation.  For pre-stimulation monitoring, the solution in 
the reservoir is transported through the first channel by negative pressure.  Next a 
secretagogue, potassium chloride, is added.  This depolarizes the cell membrane and 
causes neuropeptide release.  The solution putatively containing peptide releasates is 
transported through the second channel.  For the post-stimulation collection, the solution 
in the reservoir is exchanged with fresh ASW and then transported through the third 
channel.  After the stimulation experiment, the PDMS is removed and the exposed OTS 
coated surface is sprayed with the appropriate matrix and then imaged using MSI.  
In order to validate this design, we simulated a peptide release experiment by 
manual injection of angiotensin II (1.0 pmol) and substance P (0.5 pmol, 1347.7 Da) 
before transportation to the second channel.  As expected, angiotensin II and substance P 
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were detected in the second channel and traces (from carryover) of the peptides were 
detected in the third channel (Fig. 2.8C).  Intriguingly, substance P deposited first and 
angiotensin II deposited afterward.  This phenomenon appears to be due to the 
differential partitioning of these materials onto the OTS surface in a process analogous to 
thin layer chromatography (TLC).  We observed a similar effect in another trial that used 
1.0 pmol substance P and 1.0 pmol angiotensin II; in this case, the entire channel was 
covered by substance P without angiotensin II; we suspect that the angiotensin II eluted 
from the device (data not shown).  
 The MS image shown in Fig. 2.8D demonstrates the selective sampling of 
secreted neuropeptides from neurons.  As shown in Fig. 2.8B, five Aplysia bag cell 
neurons placed into the reservoir were stimulated by elevated potassium chloride (final 
concentration 60 mM).  As a result, two well-characterized peptides from bag cell 
neurons were detected:
33, 41
 acidic peptide (AP), with a protonated mass-to-charge ratio 
(m/z ) of 2961.3, and egg laying hormone (ELH), with a protonated m/z of 4385.2.  We 
also observed the “TLC-like” separation between AP and ELH as shown in Fig. 2.8D.    
 
2.4.5 Single Cell Analysis 
Can this approach be adapted for single cell measurements?  In order to maximize 
releasate collection and control stimulation protocols, we modified the first device so that 
the cell is loaded and located in a channel rather than a larger-volume reservoir, and 
combined this set up with optical microscopy.  The latter is problematic when using 
silicon substrates; silicon surfaces do not facilitate optical microscopy because they are 
not transparent at these wavelengths.  We therefore modified the device design as 
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illustrated in Fig. 2.9A.  In this case, the surface is a glass slide with a C18 functionalized 
gold strip (yellow band in Fig. 2.9A) that collects releasate from a single cell.  This 
PDMS device consists of a main channel, in which cells can be loaded, and a collection 
area.  Similar to our prior device, the collection area contains three channels branching 
off from the main channel area overlapping the C18 functionalized surfaces.  The 
channels can be used to collect analyte from cells and allow the temporal isolation of 
peptide release.  Here a single Aplysia bag cell neuron was loaded into the main channel 
(see Fig. 2.9B).  The solution was then collected from the cell for 15 min before elevated 
KCl (60 mM) was added to the first solution cell channel as our pre-stimulation control; 
next, the flow was redirected to the middle channel for 15 min using pressure-driven 
flow.  After the releasate was collected, 15 min post-stimulation solution was collected in 
the third channel.  The MS image is shown in Fig. 2.9C, with each channel defined with a 
rectangular box.  The peak for AP is shown in blue, and is localized in the channel that 
collected the stimulated material.  Mass spectra for the channel pre-stimulation (Fig. 
2.9D, upper) and during stimulations (Fig. 2.9D, lower) show released peptides including 
AP and alpha bag cell peptide (-BCP1-9), m/z 1122.6.   If greater temporal information is 
desired, additional collection channels can be added to this device. 
 
2.5 Conclusions 
The ability of MS to characterize peptide and proteins ensures its use in an 
increasingly wider range of applications.  Mass limited samples are becoming more 
common, requiring the development of enhanced small-volume measurement 
technologies.  To meet this challenge, MS, in combination with a microfluidic sampling 
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and manipulation system, is used here to create a flexible scheme for monitoring neuronal 
release.  The use of microfluidics with a functionalized surface, interfaced with MSI, 
provides molecular maps of neuropeptide release.  This approach allows for the study of 
the modulation of neurotransmission within engineered neuronal circuits inside a 
microfluidic device.  Because MSI allows a larger surface device to be probed, it allows 
devices with multiple collection areas containing different collection materials to be 
probed via MS.  
The surface coverage experiments on the microfluidic device with a serpentine 
channel showed promising results that the channel length covered by a peptide increased 
with the amount of that peptide, indicating that the adsorption length could be used as a 
measure for the sample amount.  This quantitation approach was not completely validated 
here, for example, the device-to-device reproducibility needed to be tested, the influence 
of experimental parameters such as sample concentration and flow rate on the length 
measurements was not studied, and the nonspecific adsorption/absorption of peptides 
onto the reservoir area and PDMS was not controlled.  Also a mathematical model 
explaining this approach needed to be developed.  The next chapter will address these 
issues and describe the details of the fully established length-based quantitation approach. 
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2.6 Tables and Figures 
 
 
 
 
Table 2.1 Adsorption of radiolabeled cytochrome c onto a hydrophobic surface.  
Reproduced by permission of The Royal Society of Chemistry. 
 
Amount in solution (fmol) Amount on surface (fmol) Percent recovery 
75 80 ± 10 110 ± 10 
125 90 ± 30 70 ± 20 
250 110 ± 40 40 ± 20 
500 180 ± 60 40 ± 10 
1000 410 ± 70 40 ± 10 
2000 700 ± 100 35 ± 5 
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Figure 2.1 Fabrication process of PDMS microfluidic device. A negative photoresist SU-
8 is used. The patterned photoresist on the silicon wafer is used as a master for molding 
PDMS devices. 
48 
 
 
 
Figure 2.2  Experimental overview of the process of collecting and measuring neuronal 
analysis using a microfluidic device.  (A)  Isolated neuronal tissue is digested by 
proteases and desheathed.  The image shows a desheathed Aplysia ganglion.  (B) 
Individual neurons are loaded into the sampling chamber of the microfluidic device.  (C) 
Neurons are chemically stimulated and their releasate transported through microfluidic 
channels and collected on the functionalized surface.  (D) The microfluidic device is 
peeled off from the surface, and the appropriate matrix-assisted laser 
desorption/ionization matrix solution is sprayed.  (E) The matrix coated surface is 
inserted into a MALDI time-of-flight (TOF) instrument and mass spectra acquired in a 
spatially resolved manner from the surface. Reproduced by permission of The Royal 
Society of Chemistry. 
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Figure 2.3 Sampling peptides on a functionalized surface using a microfluidic device.  
(A) Schematic illustration of four channels (0.2 mm × 0.01mm × 4.5 mm) and a cartoon 
showing peptide sampling on an OTS surface in a microchannel.  (B) MS image of four 
different peptides at 0.5 pmol: bradykinin, 757.4 Da (red), angiotensin II, 1046.5 Da 
(green), substance P, 1347.7 Da (blue), renin substrate, 1758.9 Da (yellow).  Scale bar = 
1 mm.  (C) Mass spectra of the four different peptides; spectrum colors correspond to 
those used in the MS image.  Reproduced by permission of The Royal Society of 
Chemistry. 
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Figure 2.4 Depletion of angiotensin II along a serpentine channel.  (A) Schematic of the 
design of the PDMS device consisting of a 114-mm-long serpentine microchannel (200 
µm wide × 10 µm high) and two reservoirs, each 2 mm in diameter; one is a loading 
reservoir and the other is connected to a piece of tubing for flow control.  (B) MS image 
of 1.0 ng angiotensin II; (C) MS image of 2.5 ng angiotensin II with an overlay of an 
image of the PDMS device; and (D) MS image of 4.0 ng angiotensin II.  Scale bar = 1 
mm.  Reproduced by permission of The Royal Society of Chemistry. 
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Figure 2.5 MS images of substance P drawn through the serpentine channel illustrated in 
Fig. 2.4.  Substance P is visualized in orange color. Grey color indicates the imaging 
areas.  (A) 1.0 ng substance P, (B) 2.0 ng, (C) 4.0 ng, and (D) 6.0 ng. 
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Figure 2.6 MS images of 5 ng substance P on silicon surfaces derivatized with different 
reagents.  Substance P is visualized in orange color.  (A) Silicon surface treated with 
DMAPTS, (B) APTS, and (C) OTS.  
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Figure 2.7 MS images of peptides on silicon surfaces derivatized with DMOPAC.  (A) 5 
ng substance P in DI water was dragged through the serpentine channel.  (B) 5 ng 
substance P in a pH = 12.5 buffer, and (C) 5 pmol acidic peptide in DI water.  Yellow 
represents substance P and pink, acidic peptide. 
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Figure 2.8 Temporal analysis of released neuropeptides from five Aplysia bag cell 
neurons stimulated using potassium.  (A) Schematic of the design of the PDMS device 
with three sampling channels and a reservoir.  Circled numbers outline the releasate 
sampling procedure: (1) pre-stimulation, (2) during stimulation and (3) post-stimulation.  
Scale bars = 1 mm.  (B) Photograph of the PDMS device filled with ASW.  Each 
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sampling channel is connected to a piece of tubing for external flow control.  Left 
photograph is a magnified image of the reservoir containing five bag cell neurons.  (C) 
MS image of experimental simulation of peptide release using angiotensin II (AngII), m/z 
1046.5 (green), and substance P (SubP), m/z 1347.7 (red): yellow represents the presence 
of both AngII and SubP.  A representative mass spectrum of the middle channel is shown.  
(D) MS image of Aplysia bag cell neuron release stimulated using elevated potassium: 
AP, m/z 2961.3 (red) and ELH, m/z 4385.2 (green).  Yellow represents the presence of 
both AP and ELH.  A representative mass spectrum from the middle channel surface is 
shown at the bottom.  Reproduced by permission of The Royal Society of Chemistry. 
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Figure 2.9 Analysis of release from a single Aplysia bag cell neuron.  (A) Schematic of 
the device containing a channel for cell placement, and three channels for peptide 
collection.  The functionalized gold surface is indicated.  (B) Image of a cell in the 
microchannel prior to stimulation.  Scale bar = 100 µm.  (C) MS image of neuronal 
releasate from the surface collected after the experiment.  AP is shown in blue.  (D) 
Representative mass spectra of an area with (1) only matrix peaks and (2) a region with 
bag cell neuron releasate.  Shown are AP and alpha bag cell peptide (α-BCP1-9), m/z 
1122.6.  Reproduced by permission of The Royal Society of Chemistry. 
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CHAPTER 3 
 
QUANTITATION OF PEPTIDE RELEASE FROM NEURONS 
 
 
3.1 Notes and Acknowledgements 
 This chapter was mainly adapted from a manuscript submitted to Lab on a Chip 
(Ming Zhong, Chang Young Lee, Callie Croushore and Jonathan V. Sweedler, “Label-
free quantitation of peptide release from neurons in a microfluidic device with mass 
spectrometry imaging,” submitted on November 8, 2011) The main objective here was to 
develop a unique method to quantify released neuropeptides in microfluidic devices 
based on the adsorption length measured with mass spectrometry imaging. This work was 
performed by several individuals and is included here for completeness. The experiments 
and section “Modeling the molecular adsorption and separation in microchannels” were 
performed by Dr. Chang Young Lee. The experiments of scintillation measurements of 
peptide absorption were performed by Callie Croushore. The preparation of the 
manuscript involved all coauthors but I took the lead in manuscript preparation. This 
work was supported by the National Science Foundation, Award No. DMI-0328162, the 
National Institute on Drug Abuse, Award No. P30DA018310, and the National Institute 
of Neurological Disease and Stroke, Award No. R01NS031609.    
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3.2 Introduction 
As mentioned in Chapter 2, microfluidics has made significant contributions to 
analytical chemistry since the technology was first introduced.
1,2
 The microfluidic 
devices described in the previous chapter are good examples of how the small volumes in 
microdevices enable handling of mass-limited samples with minimal reagent 
consumption, control of local microenvironments, and integration of multiple processing 
steps into a single system. It is not surprising that microfluidics has been broadly used to 
investigate low-amount analytes
3-6
 and to provide promising platforms that mimic in vivo 
environments for cell-based biological studies.
7-9
   
One of the challenges in this field has been the integration of microfluidic devices 
with information-rich detection modalities. As a detection scheme, mass spectrometry 
(MS) can unambiguously identify multiple analytes simultaneously from a small-volume 
biological sample without prior preselection. In particular, matrix-assisted laser 
desorption/ionization (MALDI) MS offers several advantages, such as tolerance to salts 
and other contaminants and spectra that are easy to interpret, making it quite useful for 
proteomic and peptidomic studies, including investigations of nervous system tissues.
10-12
 
Microfluidic systems can be readily interfaced with MALDI offline, either by depositing 
eluents from the device onto a MALDI target
13
 or by directly using a substrate as the 
target.
14-16
 With the development of MALDI MS imaging, spatial information can be 
added to the characterization process by allowing measurements of biomolecular 
distributions across samples.
17,18
 As highlighted in Chapter 2, we demonstrated MALDI 
imaging from a poly(dimethylsiloxane) (PDMS) device comprised of a reservoir for 
accommodating cells and a derivatized surface for collecting secreted materials.
19
 Direct 
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imaging of the surface revealed areas in the device containing both known and unknown 
analytes, without prior knowledge of their exact locations. Here, we adapt that earlier 
device to achieve improved accuracy and precision. 
Although we are interested in obtaining qualitative information on the molecules 
present in a sample, it can also be important to know their quantity. However, MALDI is 
not considered quantitative because peak heights are not always directly related to the 
amount of analyte present.
20
 The reasons for the disconnect between peak heights and 
analyte amounts include uneven distributions of analytes within matrix crystals, varied 
ionization efficiencies that depend on the molecular structure and environment, and ion 
suppression effects, especially from complex mixtures.
21,22
 One solution is to use stable 
isotopic labeling, which overcomes several of the challenges of direct quantitation with 
MS.
23,24
 For absolute quantitation, an internal standard that incorporates a heavy isotope 
(e.g., 
2
H, 
13
C, 
15
N, or 
18
O) is added for each corresponding analyte and accurate 
measurements are done by comparing the intensity or area of paired peaks. For relative 
quantitation, peptides in two samples are differentially labeled with a distinguishable 
mass difference between two isotopic forms and are then combined for comparison. 
Stable isotopes can be incorporated into peptide molecules either through metabolic 
labeling
25
 or by attachment with isotopic tags.
26
 Owing to the development of a number 
of novel labeling schemes,
24,27,28
 significant progress has been made in quantitative MS; 
it has been applied in the analysis of various biomolecules,
29-32
 enabling measurement of 
contents from single cells.
33
 However, using stable isotopic labeling within microfluidic 
devices presents several challenges: labeling adds multiple steps to the sample 
preparation process, organic labeling reagents may not be compatible with PDMS and are 
63 
 
toxic to live cells, and finally, the labeling reactions inevitably dilute the mass-limited 
samples. Therefore, a more amenable and simple quantitation strategy is needed for 
PDMS devices. 
Here we modify an approach used in many diagnostic tests in which the length of 
color change along a strip is related to the amount of analyte. For example, in a home 
cholesterol test kit, a blood sample is drawn onto a test strip and cholesterol contained in 
the sample reacts with enzymes and chemicals deposited on the strip. The color of strip is 
changed during this reaction, and the zone of remaining cholesterol migrates further up 
the strip. The reaction continues until all the cholesterol is consumed. The final result is 
that the amount of cholesterol in the blood sample can be measured from the length of 
color band by using a standard conversion chart. The test is robust and offers a 
quantitative measurement that is independent of the viewer‟s color sensitivity, and is the 
approach adapted here. We combine this with off-line MALDI MS imaging to 
demonstrate that the adsorption length in a microfluidic channel is proportional to analyte 
amount. Because the ability of a surface to adsorb an analyte is fixed per unit length, the 
larger the quantity of sample, the longer the section of channel it will cover. This 
approach is label-free. We have adapted our prior device outlined in Chapter 2 for such 
measurements,
19
 improving its design and implementing a more controlled solution flow. 
Calibration curves obtained with multiple standards show the expected linear relationship 
between length and amount; a model of the adsorption process supports the linear nature 
of length-to-amount for multiple analytes. We demonstrate the ability to measure peptide 
release from a small number of Aplysia bag cell neurons, a well-characterized 
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neurosecretory model,
34,35
 and are able to extract absolute quantitative information for the 
released peptides. 
 
3.3 Experimental 
Appendix A contains a master list of all abbreviations used in this chapter. 
3.3.1 Materials and Reagents 
Unless stated otherwise, organic solvents were from Fisher Scientific (Fair Lawn, 
NJ) and all the other chemicals from Sigma-Aldrich (St. Louis, MO). The PDMS 
prepolymer kit, Sylgard 184, was purchased from Dow Corning (Midland, MI). Silicon 
wafers were obtained from WRS Materials (Spring City, PA); 2-
[methoxy(polyethyleneoxy)propyl]trimethoxysilane (OEG, 90%) was from Gelest, Inc. 
(Morrisville, PA) and used as received. Negative photoresist SU-8 2050 and developer 
were obtained from MicroChem Corp. (Newtown, MA). Positive photoresist AZ 5214-E 
and developer were from AZ Electronic Materials Corp. (Somerville, NJ). Acidic peptide 
(AP) was synthesized at the Roy J. Carver Biotechnology Center (University of Illinois at 
Urbana-Champaign). α-bag cell peptide [1-9] (αBCP, 80%) was purchased from 
American Peptide Company, Inc. (Sunnyvale, CA). Angiotensin II (Ang II), (5-L-
Isoleucine) [tyrosyl-3,5-
3
H(N)] (specific activity = 50 Ci/mmol, concentration 1 mCi/mL) 
was from American Radiolabeled Chemicals, Inc. (Saint Louis, MO). Ultima Gold LLT 
liquid scintillation solution was purchased from Perkin Elmer. Filtered artificial sea water 
(ASW, pH 7.8) contained 460 mM NaCl, 10 mM KCl, 10 mM CaCl2, 22 mM MgCl2, 26 
mM MgSO4, 2.5 mM NaHCO3, and 15 mM HEPES.  
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3.3.2 Substrate Derivatization 
The derivatization process is illustrated in Fig. 3.1. A piece of silicon wafer was 
patterned with AZ 5214-E photoresist via standard photolithography so that about 2/3 of 
the bare silicon was exposed. The patterned substrate was dipped in a mixture of 15 mL 
chloroform and 35 mL hexane with octadecyltrichlorosilane (OTS, 0.8% v/v) for 10 min 
and then in hexane for 10 min, as modified from previous procedures.
19,36
 The chip was 
rinsed with acetone to remove the photoresist and dried at 70 °C for 3 h. The partially 
derivatized surface was immersed in 50 mL toluene containing OEG (0.8% v/v) 
overnight, followed by immersion in toluene for 1 h, rinsing with methanol, and drying at 
70 °C for 2 h.
37,38
 Substrates were rinsed with methanol and water sequentially and dried 
with nitrogen directly before use.  
 
3.3.3 Device Fabrication 
Microfluidic devices consisted of PDMS with channel features sealed onto 
derivatized silicon substrates. The PDMS pieces were formed by molding Sylgard 184 
onto a photolithographically patterned SU-8 master. Small pieces of silicone tubing 
(Helix Medical, LLC, Carpinteria, CA) were glued onto SU-8 features that served as 
device outlets.
39
 The PDMS prepolymer was then poured onto the master and cured at 
70 °C overnight. The inlet reservoir was made with an AcuPunch (Acuderm, Inc., Ft. 
Lauderdale, FL) biopsy punch of 1.5 mm diameter. To reduce sample loss to the PDMS 
material, the channels were sequentially treated with 5:1:1 H2O:HCl:H2O2 for 5 min, H2O 
for 5 min, OEG for 30 min, and finally flushed with 500 μL of deionized (DI) water 
(Milli-Q Biocel, Millipore Corporation, Billerica, MA) to yield OEGylated PDMS, as 
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described previously.
40
 For plasma treatment, the PDMS was subjected to oxygen plasma 
for 30 s at 100 W with a March Plasmod (March Instruments, Concord, CA) oxygen 
plasma system and stored in DI water for future use. Extracted PDMS was prepared 
according to the previous procedure.
41
 Prior to use, PDMS pieces were rinsed with 
methanol and water and dried with nitrogen. 
 
3.3.4 Scintillation Measurements of Peptide Absorption 
The radiolabeled Ang II was diluted to 1 pmol/μL with DI water, and 2 μL 
aliquots of the solution were incubated for 4 h in microchannels made of five different 
types of PDMS: native, plasma-treated, extracted, OEGylated, and OEGylated extracted. 
Incubated solutions were pushed out of each device through polytetrafluoroethylene 
tubing (Cole-Parmer Instrument Company, Vernon Hills, IL) and into microcentrifuge 
tubes. The devices were then rinsed with 2 µL of DI water and the rinsing solution was 
pushed into the same microcentrifuge tube. The combined Ang II and rinse solutions 
were pipetted into a 20 mL glass scintillation vial; 5 mL aliquots of liquid scintillation 
solution were added to each vial and counted with a liquid scintillation counter (Beckman 
LS 6500, Beckman Coulter, Inc., Brea, CA); 2 µL aliquots of the Ang II solution before 
incubation were also measured as a control. 
 
3.3.5 Standard Peptide Calibration Experiments 
AP and αBCP were used as received and dissolved in ASW to various 
concentrations (1–10 pmol/μL) for storage. The outlet tubing of the PDMS device was 
connected to a 25 μL syringe (Hamilton Company, Reno, NV) controlled by a Harvard 
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PHD 2000 syringe pump (Harvard Apparatus, Holliston, MA) set at the refill mode. For 
calibration with a single peptide, a desired amount of AP was loaded into the inlet 
reservoir and pulled through the channel to the outlet at the rate of 0.1 μL/min. For 
multiple peptide experiments, AP and αBCP were mixed in the inlet prior to assay. Three 
or more individual samples were tested for each amount, and the mean and standard error 
of adsorption length were calculated. The best-fit straight lines for adsorption length 
versus amount were obtained.  
 
3.3.6 Cell Experiments 
Aplysia californica (100–150 g, National Resource for Aplysia, Miami, FL) were 
anesthetized by injecting 390 mM of MgCl2 solution equal to 1/2 of each animal's body 
weight. The abdominal ganglia with adjacent nerves were dissected and incubated in 
ASW containing 10 mg/mL protease from Streptomyces griseus at 34 °C for 90 min, 
modified from previous experiments.
42
 This treatment facilitated removal of the 
connective sheath tissue around the ganglia and isolation of individual neurons. After 
washing with fresh ASW, individual bag cells were isolated and plated into the inlet 
chamber of a microfluidic device. Cells were allowed to attach to the substrate for at least 
1 h and then stimulated by adding an elevated KCl solution (final concentration 55 mM). 
Following a 15 min incubation, released peptides were collected onto the OTS-
functionalized surface by transporting the extracellular media with the syringe pump. The 
pump was stopped right before the inlet reservoir became completely empty and the 
remaining liquid was removed. The flow was then resumed until the solution in the 
channel was depleted. 
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3.3.7 MS Imaging 
After peptide collection, the PDMS was peeled off of the silicon substrate. A 
MALDI matrix, 2,5-dihydroxybenzoic acid (DHB, 10 mg/mL in 50%/50% 
acetonitrile/water), was sprayed onto the surface with an airbrush (Paasche Airbrush 
Company, Chicago, IL) placed at a distance of ~15 cm. The substrate was then taped onto 
a modified target plate and MALDI characterization was performed with a Bruker 
UltrafleXtreme time-of-flight (TOF) mass spectrometer (Bruker Daltonics, Inc., Billerica, 
MA) in the reflectron mode. MS images were obtained at 100 or 200 μm resolution with 
each spot summed from 200 laser shots. Mass calibration was done with peptide 
calibration standard II (Bruker Daltonics). The images were analyzed with flexImaging 
software (Bruker Daltonics), with the threshold value for analyte detection set at 10% of 
the maximum intensity on the OTS surface. Individual mass spectra were analyzed with 
FlexAnalysis (Bruker Daltonics) and replotted with Origin, version 8.5 (OriginLab 
Corporation, Northhampton, MA).  
 
3.4 Results and Discussion 
3.4.1 Minimizing Peptide Losses to PDMS 
Our goal was to design a device that allows the efficient collection of the media 
around cultured cells and its subsequent characterization via off-line MS. Because of the 
small scale of the fluidics, there is a large surface-to-volume ratio and so surface loss 
becomes a significant concern. Obviously, peptides that either partition into or adsorb 
onto surfaces in the culturing chamber or fluidic channels cannot be measured via MS 
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and are lost. Hence, we carefully minimized sample losses using surface derivatization 
protocols and then characterized those losses using sensitive radionuclide detection.  
  In order to minimize partitioning of the molecules into the PDMS material, its 
chemical properties have to be optimized. This includes adsorption due to the 
hydrophobicity of PDMS, and the even the diffusion of uncrosslinked oligomers and 
remaining platinum catalysts into bulk channel solutions.
41,43,44
 Several surface treatment 
protocols have been employed in the past. Oxygen plasma treatment is a widely-used 
method that renders PDMS hydrophilic, making it more amenable to aqueous solutions.
45
 
PDMS extraction, which consists of a series of solvent washes to remove the uncured 
oligomers and remaining platinum catalysts used to cure the polymer, significantly 
improves cell viability in low-density cultures.
41
 OEGylation, by derivatizing the PDMS 
surface with OEG, has been shown to reduce protein absorption and to provide more 
hydrophilic channels.
38,40
 By measuring the amount of peptide lost by our devices with 
these treatments, we obtain a more accurate measurement of total peptide release from 
the neurons.   
We measured these losses using radionuclide detection because of its low 
detection limits and absolute quantitation abilities. We incubated 
3
H-labeled Ang II in a 
PDMS device containing 1 mm diameter reservoirs and a straight channel (200 μm wide, 
100 μm high, 10 mm long), and then measured the loss of peptides from the surface-
treated PDMS materials compared to the native. Recovered peptides from the native, 
plasma-treated, extracted, OEGylated and OEGylated extracted PDMS were quantified. 
Fig. 3.2 shows the signal from radiolabeled Ang II recovered from each type of PDMS 
compared to non-incubated solutions. Approximately 50% of the peptide was recovered 
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from native, plasma-treated, and extracted PDMS; whereas recovery of 70–75% was 
observed for OEGylated and OEGylated extracted PDMS, indicating a significant 
reduction in loss upon OEG treatment (p < 0.05, refer to Fig. 3.2). Furthermore, although 
the absorption of Ang II into the extracted PDMS (and also the plasma-treated one) was 
not appreciably different from the native PDMS (p = 0.90), absorption was significantly 
reduced (p < 0.001) when the extracted PDMS was OEGylated. While OEG treatment 
did not eliminate sample loss, it certainly reduced it. There was no significant difference 
(p = 0.35) between the OEGylated and OEGylated extracted PDMS. Therefore, 
OEGylated PDMS was utilized here; however, the combined OEGylated and extracted 
PDMS will be explored in future studies as it may aid cell viability.  Peptide losses also 
depend on specific device dimensions, possibly making these treatments even more 
important for the smaller scale and longer serpentine channels explored below. 
 
3.4.2 Minimizing Peptide Losses to Reservoir 
 In a microfluidic device, the area of a reservoir is significant compared to the area 
under the microchannel. For example, a circular reservoir with a diameter of 1.5 mm is 
equal to a 9 mm long channel with a width of 200 μm in terms of area. Therefore the loss 
of peptides into the reservoir is significant if the reservoir area is also able to adsorb 
peptides. The MS images in Fig. 2.4 and 2.5 show that strong signals were detected 
inside the reservoir, when the microfluidic device with a serpentine channel was used to 
sample different amounts of standard peptides, Ang II and substance P. The entire 
substrate of the device was coated with OTS. In order to reduce the nonspecific 
adsorption at the reservoir, the surface there needs to be nonadhesive to peptides.  
71 
 
 Different methods were tested to pattern the substrate with the reservoir area 
resistant to peptide adsorption and the rest of area OTS-coated. In one method, an 
assembled device containing the PDMS with an open inlet and the OTS substrate was 
treated with oxygen plasma at 100 W for 30 s (Fig. 3.3A). With oxygen plasma treatment, 
the OTS layer was removed to expose the silicon surface. As only the reservoir was open 
to the air, that area would be deprived of OTS specifically. Fig. 3.3B shows a 
microscopic image of the surface after plasma treatment; the reservoir area appeared 
distinct from the other part. Because of the different hydrophobicity of silicon and OTS, 
water only wetted the reservoir (Fig. 3.3C). However, it was found that the silicon surface 
can also adsorb peptides. Moreover, the plasma penetrated into the channel and reacted 
with OTS there, causing nonconsistent results in terms of peptide adsorption. Another 
method was to partially coat the silicon substrate with OTS by dipping about 2/3 of the 
substrate into the OTS solution. The partial coating resulted in an evident boundary 
between silicon and OTS (Fig. 3.4A) and a difference in hydrophobicity of these two 
areas (Fig. 3.4B). The PDMS piece with the channel was then aligned with the boundary 
to ensure that the reservoir was on top of the silicon surface. However, because silicon 
could also capture peptide molecules, as mentioned above, this method was not able to 
reduce nonspecific adsorption.  
 The self-assembled monolayer (SAM) of alkanethiol on gold has different 
chemical properties based on its end functional group and is widely used for surface 
patterning. An OTS surface can be partially coated with gold by using a PDMS piece to 
block a portion of the surface. The gold part was then coated with a SAM of 
oligo(ethylene glycol) ((11-Mercaptoundecyl)tetra(ethylene glycol), abbreviated as OEG) 
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that prevents the adsorption of biomolecules. As a result, a surface patterned with OEG 
and OTS was formed. The effectiveness of OEG layer was first tested on a microfluidic 
device on a surface completely coated with OEG (Fig. 3.5A). In this device, 2 ng 
substance P was flowing through the channel. The MS image in Fig. 3.5B shows 
essentially no signals detected in the channel (substance P was visualized in the orange 
color). In a device with a partial gold coating (Fig. 3.5C), the PDMS was aligned with the 
boundary on the substrate so that the reservoir was on the gold side. 3 ng substance P was 
introduced into the system. No significant signals were detected in the channel on the 
OEG-coated gold, while strong signals were on the OTS side (Fig. 3.5D). The results 
demonstrate the capability of OEG to prevent peptide adsorption. Peptide signals in the 
reservoir were likely from the residual peptides left behind when the liquid in the 
reservoir was dried out.  
 The partial gold coating method is effective in reducing nonspecific adsorption, 
but gold deposition adds additional processing steps to chip fabrication and increases the 
cost. We modified this approach by utilizing a positive photoresist and OEG-silane 
instead, as depicted in Fig. 3.1. The photoresist was used to block a certain area of the 
silicon substrate and the OEG group was attached onto the substrate through silanization 
reaction. The detailed fabrication procedure was described in Section 3.3.2 above and the 
effectiveness of this treatment will be demonstrated in the next section. 
 
3.4.3 Device Design and Fabrication 
Our microfluidic device contains a serpentine channel (200 μm wide, 50 μm high, 
110 mm long) with inlet and outlet ports (Fig. 3.6). The dimensions of the channel permit 
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a stable flow at the rate of 50 nL/min to 5 μL/min. Silicone tubing embedded into the 
PDMS structure ensures a good seal at the outlet and thus, stable liquid flow. The cell 
culture/sampling chamber is the inlet to the device; a diameter of 1.5 mm was optimal for 
ease of liquid handling and cell loading as well as minimizing sample losses that occur 
with too large an inlet reservoir. Fig. 3.7 compares the adsorption length of 3 pmol AP 
with different inlet sizes. The test was performed in a microfluidic device with a simple 
straight channel (200 µm width, 50 µm height, 30 mm length) on the OTS silicon 
substrate. Compared to the 2 mm diameter (Fig. 3.7A), the same amount of peptide 
covered a longer segment of channel with the 1.5 mm inlet (Fig. 3.7B), indicating a 
decrease in sample loss to the reservoir. By gluing a capillary (Polymicro Technologies, 
Inc.) onto the inlet feature of the SU-8 master before pouring the PDMS prepolymer, a 
void equal in size to the outer diameter of the capillary (370 µm) was formed after PDMS 
was cured and the capillary was removed. The longest adsorption length was achieved at 
this inlet size (Fig. 3.7C). However, it became very difficult to add liquid or load cells 
into the inlet when the reservoir diameter was 1 mm or less. In this case, the solution had 
to be added on top of the inlet, and be drawn into the inlet and channel by applying a 
negative pressure at the outlet. During this process, some liquid might not have been 
introduced into the channel, as the surface around the inlet was not completely flat, 
causing inconsistent sample loss and variation in adsorption length measurements 
between different experiments. Based on these considerations, the 1.5 mm inlet size was 
used for the following calibration and cell release experiments.  
We divided the substrate into two regions, each with different surface chemistries. 
About 2/3 of the silicon substrate underneath the channel is functionalized with OTS for 
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peptide collection.
46,47
 The other 1/3 is functionalized with our OEG treatments to reduce 
peptide losses from the sampling/inlet chamber. The PDMS device is carefully aligned 
with the OTS-OEG boundary, as shown in Fig. 3.6.  
The effectiveness of OEG to reduce peptide adsorption is demonstrated in Fig. 3.8. 
In the two devices in Fig. 3.8A and B, the OTS-OEG boundary was aligned to intersect 
with channels in different directions. 5 pmol AP was added to the inlet reservoir and the 
solution was transported through the channel. Fig. 3.8A and B show the resulting MS 
images, with AP signals visualized in yellow. Essentially no AP signals were detected in 
the channel on top of OEG, indicating the excellent capability of OEG to repel adsorption 
of peptide molecules. In contrast, significant AP signals were detected on the OTS side. 
There were still AP signals in the inlet, most likely from residual peptides left behind as 
the liquid dried in the reservoir. The capability of OEG was further confirmed by 
comparing the adsorption length and intensity profile of 5 pmol AP in two devices with 
the surface coated with OTS completely and the OTS-OEG surface respectively. The MS 
images are shown in Fig. 3.8C and D, in which the signal intensity of AP at each spot is 
visualized in a rainbow color gradient. The white indicates the highest intensity, while the 
dark blue the lowest. In the OTS surface, strong signals were detected inside the reservoir, 
while the signals there were weaker on the patterned surface. The adsorption length on 
the OEG-OTS surface was much longer than the OTS surface, indicating that OEG is 
indeed efficient in preventing nonspecific adsorption. 
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3.4.4 Modeling the Molecular Adsorption and Separation in Microchannels 
Before using the device to quantify peptides and to gain insight into the device 
design and operation, we developed a simplified kinetic model to describe the molecular 
adsorption in the microfluidic device. Consider a plug of analytes (A) with a width (W) 
of 200 μm, length (L) of 200 μm, and height (H) of 10 μm. The plug flows through a 10 
cm-long microchannel at a linear velocity of v (Fig. 3.9A). The channel is divided into 
200 μm-long segments of the same size as the plug (total 500 segments). In each segment 
the analytes are allowed to adsorb irreversibly onto adsorption sites (θ) at the bottom 
surface, occupying Aθ sites, with the adsorption rate constant kA for the time period of τ = 
L/v.  
 AA Ak                             (3.1) 
The total number of binding sites is constant and determined by the surface area (W × L) 
and the size of the A molecule (assumed 1 nm for this study). From the site and material 
balance: 
      AT                (3.2) 
][][][ AAA O                (3.3) 
where [θ]T and [A]o represent the total binding sites in a segment and the concentration of 
A when entering each segment, respectively. We assume a bimolecular elementary 
reaction, monolayer adsorption, no interaction between analytes, and no surface 
migration of analytes. Therefore, the adsorption rate is 
          ))((][  AAAkAk
dt
Ad
TOAA                       (3.4) 
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Upon completion of the reaction in a segment, the plug then discretely moves to the next 
segment where further adsorption takes place. The process repeats until the analyte plug 
migrates along the entire channel length. 
The solutions are obtained for an initially clean substrate using ODE solvers in 
MATLAB, and Fig. 3.9B shows the surface coverage of the analyte ([Aθ]/[θ]T) versus 
channel distance for amounts ranging from 1 pmol to 30 pmol. kA = 10000 M
-1
s
-1
 and v = 
2.5 mm/s are used, and a coverage of 1 indicates saturation. The length covered by an 
analyte increases with amount. The linear result of length versus amount supports our 
concept of quantitation. When this sample is analyzed using MS imaging, the signal 
intensity is related to the surface coverage. We find that using the end point of the analyte 
band (i.e., adsorption length), rather than fitting the MS intensity profile directly to the 
model, is a robust measure for quantitation. Here we defined the threshold surface 
coverage above which the presence of analytes can be detected with MALDI to be 0.1. 
With this criterion the adsorption length versus amount is plotted at v = 2.5 mm/s for kA 
values of 5000 M
-1
s
-1
, 10000 M
-1
s
-1
, and 50000 M
-1
s
-1
 (Fig. 3.9C). The adsorption length 
is linearly proportional to the amount, and turns out to be insensitive to kA. The result 
suggests that our quantitation method, the amount-to-length conversion, can be applied to 
peptides with different adsorption characteristics. 
For a given device design and a system to be analyzed, the only parameter under 
external control is flow rate. Understanding the effect of flow rate thus aids in obtaining 
reliable quantitation. In Fig. 3.9D, the surface coverage for 10 pmol is plotted at a linear 
velocity of 0.83 mm/s to 42 mm/s, which corresponds to 0.1 μL/min to 5 μL/min for 
continuous feed (kA = 10000 M
-1
s
-1
). To fully utilize the adsorption capability of the 
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substrate, the flow rate should be low so that the convection timescale remains longer 
than the reaction timescale (
AACk
1 ), where CA denotes initial analyte concentration. 
When this condition is met, the adsorption length is insensitive to the flow rate and varies 
only with the amount of analytes, as shown in Fig. 3.9E. 
For a mixture of analytes with different adsorption rate constants, a separation 
between them is expected due to their differential adsorption. We made several 
simplifying assumptions here. We assumed that each adsorbate molecule (A, B, and C) 
occupy the same area of 1 nm × 1 nm, and differ only by adsorption rate constants. The 
number of analyte binding sites per segment (200 µm × 200 µm) is therefore 4 × 10
10
 
with 500 segments along the 10 cm-long channel. The size may be varied depending on 
the analytes of interest. 
Consider adsorption of two analytes A and B. When two analytes adsorb onto the 
substrate, the adsorption is competitive between the two. 
 AA Ak                                                                                                               (3.5) 
 BB Bk                                                                                                                (3.6) 
Using the site and material balance:  
        BAT                                                                                                     (3.7) 
][][][ AAA O  , ][][][ BBB O                                                                               (3.8) 
the adsorption rate can be described: 
            ))((][  BAAAkAk
dt
Ad
TOAA                                                 (3.9) 
            ))((][  BABBkBk
dt
Bd
TOBB         (3.10) 
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The coupled differential equations can be solved for an initially clean surface 
( [Aθ] = [Bθ] = 0 at t = 0), and the solutions are plotted in Fig. 3.9F. We used the ode15s 
function in MATLAB (MathWorks, version 7.12, R2011a) to solve the coupled ordinary 
differential equations. [A]o and [B]o in each segment are determined based on the amount 
of A and B consumed by the previous segment. Consider 5 pmol each of A and B with 
adsorption rate constants kA = 10kB = 100000 M
-1
s
-1
. The adsorption is now competitive 
between the two. When the analyte plug flows down the channel, preferential adsorption 
of A occurs, followed by adsorption of B as A in the solution is depleted. The result is 
two distinct analyte bands (Fig. 3.9F). The same principle applies to a mixture of three 
different analytes (5 pmol each of A, B, and C) as shown in Fig. 3.9G. The adsorption 
kinetics of the three analytes were obtained in a similar manner by solving three coupled 
differential equations. The parameters used in Fig. 3.9G are kA = 10kB = 100kC = 100000 
M
-1
s
-1
 and v = 0.83 mm/s. In the actual experiments, analytes are continuously supplied 
to the channel as a long band rather than a plug, and a thin layer chromatography-like 
separation occurs as the mobile phase drives the adsorbates. This separation mechanism 
is not discussed further.  
 
3.4.5 Validation of the Model with a Single Standard 
Next, we experimentally validated our model using two neuropeptide standards, 
AP (m/z 2959.6) and αBCP (m/z 1122.6), two well-characterized peptides released from 
Aplysia bag cells and cleaved from the same egg laying prohormone.
48
 We first 
performed the calibration experiments with only AP to determine optimized conditions. 
The flow rates of 0.1 and 0.05 μL/min and analyte concentrations of 1 and 0.5 pmol/μL 
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were tested with the same amounts of AP. As suggested by the model, the detected 
adsorption length was insensitive to the analyte concentration and the flow rate at 0.1 
μL/min and below where 1AACk  (Fig. 3.10). Therefore, the flow rate of 0.1 μL/min 
was used for subsequent experiments to minimize experimental times. The 
reproducibility of length measurements was tested in different devices with the same 
amount of 10 pmol AP. As shown in Fig. 3.11, the measured length remains essentially 
constant in all three devices. The mean of measured length is 28.3 mm. and the standard 
error of the mean (s.e.m.) is 0.7 mm. The variance of length measurement, defined as the 
ratio of s.e.m. to mean, is below 3%. The results demonstrate the robustness of our 
quantitation method.  
Peptide standards (1, 3, 5, 10, or 15 pmol AP in ASW) were then added into the 
reservoir and pulled through the channel. The resulting MS images in Fig. 3.12A show 
the adsorbed AP, with AP signals visualized in yellow. A representative mass spectrum is 
shown in Fig. 3.12B. These images clearly demonstrate that the adsorption length 
increased proportionally with the amount of peptide introduced. Despite the large 
intensity fluctuation at individual pixels within the MS image, the signal remains obvious 
throughout until the front of the band. The observed profile well matches the model‟s 
predictions shown in Fig. 3.9B, suggesting the saturation of adsorption sites except for 
the band boundaries. A calibration curve (Fig. 3.12C) plotting the adsorption length of 
AP versus its amount shows a good linearity within the tested range (R
2
 = 0.97). The 
variance of length measurement, defined as the ratio of standard error of the mean (s.e.m.) 
to mean, is from 3% to 12% from distinct microfluidic devices. The small negative 
intercept of the fit line is primarily due to sample lost to the sampling chamber. Indeed, 
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we detected AP signals in the inlet reservoir even with OEG functionalization. However, 
when the AP solution was pulled through the channel above the OEG-functionalized 
surface, no AP peaks were detected, demonstrating the ability of OEG to prevent peptide 
adsorption. Therefore, the signals in the inlet were unlikely from peptide adsorption, but 
most likely from residual peptides left behind as the liquid dried in the reservoir. It is 
possible that the presence of an inlet contributed to the variance of measured length, but 
the linear length-amount relationship indicates that this is not a large effect. The slope of 
the calibration equation suggests that the AP occupies 2.8 mm of channel length per pmol, 
equaling to a surface coverage of 1.8 × 10
2
 pmol/cm
2
. As indicated in Chapter 2, we 
previously measured the value of Ang II as 33 pmol/cm
2
.
19
 Peptide adsorption properties 
depend on chemical structure and polarity;
49
 the slight differences in surface coverage for 
AP and Ang II are expected.  
By plotting the signal intensity at each spot with the distance from the inlet, we 
can obtain an intensity profile of a peptide along the channel. The intensity profile of 10 
pmol AP is shown in Fig. 3.13. The profile shows a large variation of signal intensity 
recorded with MALDI along the channel, demonstrating the nonquantitative nature of 
MALDI. However, a general trend is evident as indicated with a red guidance line in Fig. 
3.13. This trend is consistent with the coverage profile predicted by the mathematical 
model shown in Fig. 3.9B, with saturated coverage of peptides along the whole band 
expect partial coverage at the end. In all, experiments on AP demonstrate that 
quantitation based on the adsorption length is feasible. 
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3.4.6 Validation of the Model with Multiple Standards 
 As mentioned previously, neurons often secrete multiple peptides during 
stimulation and MS can characterize each. Thus, we wanted to determine whether two 
peptides can be simultaneously measured and if the linear length-to-amount relationship 
is still maintained. We tested our device by mixing AP and αBCP in the reservoir; the 
amount of AP was fixed at 3 pmol and αBCP varied from 1 to 15 pmol. MS images for 
each amount of αBCP are shown in Fig. 3.14A, with yellow spots for AP and green for 
αBCP. For each sample tested, two distinct bands were clearly visible. A representative 
mass spectrum for each band is shown in Fig. 3.14B, confirming that these two peptides 
were separated. Based on our model and the fact that AP deposited first on the channel, it 
appears that AP has a higher adsorption than αBCP. From each image, the adsorption 
length of the αBCP band was measured, and the calibration curve for length versus 
amount (Fig. 3.14C) demonstrates a linear relationship (R
2
 = 0.98) in the tested sample 
range. The variance of length measurement is in the range of 3 to 8%. From the slope of 
the linear fit, the surface coverage of αBCP was calculated as 1.6 × 102 pmol/cm2, close 
to the value of AP. The small positive intercept of the straight line was likely caused by 
the variance in length measurement. The series of MS images also indicate that the length 
of 3 pmol of AP remained essentially constant, suggesting that the changing amounts of 
other analytes have limited influence on the band length. This was further confirmed by 
fixing the amount of αBCP at 3 pmol and varying AP from 1 to 5 pmol; the resulting 
αBCP bands were of constant length, and the length of AP was the same as the 
corresponding length when αBCP was not present (Fig. 3.15). Therefore, this quantitation 
method is applicable when more than one analyte is present. Moreover, because each of 
82 
 
the above experiments was done on a different device, the reproducibility of imaging 
profiles demonstrates the robustness of our measurement platform. 
 
3.4.7 Measuring Neuronal Release 
Aplysia bag cell neurons, located in the abdominal ganglion, are commonly used 
as a model to study activity-dependent neurosecretion. They were used in this study to 
document the capability of our approach for quantifying peptide release from neurons. 
When the surrounding KCl concentration is elevated, the membrane is depolarized, 
leading to the release of several peptides that originate from egg laying prohormone.
35,50
 
Previous studies used intact abdominal ganglia placed in perfusion systems and the 
secreted peptides in the perfusate were quantified by HPLC
51
 or radioactivity.
50,52
 The 
results showed high variability in the amounts of peptides released from different ganglia, 
but on average, the amount of each peptide from a single bag cell was in the upper 
femtomole range, assuming about 400 bag cells per ganglion. Compared to perfusion 
systems, microfluidic devices more efficiently collect the extracellular environment with 
minimal sample loss, and allow more precise timing of chemical stimulations. Here, 15 
cells were loaded into the sampling chamber (Fig. 3.16A), and control experiments 
analyzed the media surrounding the cells without KCl stimulation. An MS image of a 
control is presented in Fig. 3.16B, in which yellow indicates AP and green, αBCP. The 
peptide signals in the reservoir were due to cell lysis occurring when the chamber was 
dried. No peptide signals associated with bag cell stimulation were detected there, 
indicating that the lysis products did not enter the channel. A representative mass 
spectrum from the channel area of the control device is shown in Fig. 3.16D. When the 
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cells were treated with 55 mM KCl for 15 min, the peaks for AP and αBCP were 
detectable in the channel (Fig. 3.16C and 3.16D). Both peptides were detected as separate, 
distinct bands, and their identities confirmed via MS. Based on the measured lengths and 
the calibration equations obtained with standards, the amount of AP released from 15 bag 
cells was estimated to be 2.3 ± 0.4 pmol, and αBCP, 1.9 ± 0.9 pmol (mean ± s.e.m., from 
3 samples), meaning that the average isolated cell in vitro released 0.15 ± 0.03 pmol of 
AP and 0.13 ± 0.06 pmol of αBCP. These values are consistent with the femtomole 
release expected from a single cell.
51,52
 The results presented here validate our approach 
for quantifying peptide release from a microfluidic device based on the adsorption length 
measured using MS imaging. 
 
3.5 Conclusions 
Microfluidics is receiving greater attention in analytical chemistry because of its 
ability to perform low-volume manipulations and work with samples such as cells. At the 
same time, MS has become the preferred technology for peptidomics and proteomics 
measurements. By combining MS with a microfluidic sampling system, we have 
successfully developed an off-line approach for quantifying the media located around 
cells for neuropeptides. The adsorption-length-based approach takes advantage of the 
imaging capability of MALDI while avoiding the challenges of conventional signal-
intensity-based quantitation by offering a simple, robust and label-free solution for 
quantitative studies. Validated using peptide standards and releasate from Aplysia bag 
cell stimulation, this approach is flexible and can be adapted to many other molecular 
classes in addition to neuropeptides. Future work will use more complex devices with 
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multiple channels and collection areas so that our analyses will include monitoring 
multiple secretion events with time and/or spatial resolution and comparison of releasate 
under different physiological conditions.  
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3.6 Figures 
 
 
 
 
 
 
Figure 3.1 Fabrication process of a silicon surface patterned with OTS and OEG. A 
positive photoresist AZ 5214 is used to block certain area of the silicon surface from OTS 
treatment.  
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Figure 3.2 Radiolabeled Angiotensin II peptide recoveries following 4 h incubations 
from PDMS subjected to different treatments, as well as the control solution before 
incubation. The p-values comparing peptide recovery from OEGylated PDMS to other 
types of PDMS are listed above each corresponding bar; the significance (p < 0.05) 
demonstrates the ability of OEG to reduce peptide absorption. Error bars represent s.e.m.  
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Figure 3.3 Removal of OTS in the reservoir with oxygen plasma treatment. (A) A PDMS 
chip with an open reservoir was placed on top of an OTS-coated silicon substrate. The 
whole device was subject to oxygen plasma treatment. (B) A microscopic image of the 
substrate after plasma treatment. The reservoir area was distinct from the rest area. (C) 
Water only wetted the reservoir area as it was more hydrophilic than the OTS surface.  
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Figure 3.4 Partial coating of silicon with OTS. (A) A silicon substrate was partially 
dipped into the OTS solution. The boundary of bare silicon and OTS was clearly 
observed after treatment. (B) Water only wetted the silicon area. 
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Figure 3.5 The method of gold patterning to reduce nonspecific adsorption in the 
reservoir area. (A) The OTS substrate was completely covered with gold, which was then 
coated with OEG. (B) A MS image of 2 ng substance P flowing in the device shown in 
(A). No substantial signals were detected in the channel area. The color of orange 
indicates the presence of substance P. (C) A microfluidic device on the silicon substrate 
patterned with OEG-gold and OTS. (D) A MS image of 3 ng substance P introduced into 
the device in (C). No significant signals of substance P were detected in the channel area 
on the gold side, while strong signals were on the OTS side. 
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Figure 3.6 Device design. The microfluidic device contains a long serpentine channel 
(200 µm width × 50 µm height × 110 mm length). The inlet reservoir is made by 
punching PDMS with a biopsy punch, and the outlet has a short segment of tubing for 
connection to a syringe pump. (Left) The chip design on a transparency mask. (Right) A 
photomicrograph of the PDMS device. Note that the substrate is patterned with OEG and 
OTS, with their boundary visualized by the grey line. The inlet is on the OEG, and the 
channel and outlet on the OTS. 
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Figure 3.7 Influence of the reservoir size on adsorption length. A microfluidic device 
with a straight channel (200 µm width × 50 µm height × 30 mm length) was used. 3 pmol 
AP was introduced into each device and the signals are visualized in yellow. (A) The 
diameter of the inlet is 2 mm. (B) Diameter of 1.5 mm. (C) The reservoir was made by 
gluing a capillary with the outer diameter of 370 µm onto the master before PDMS curing.  
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Figure 3.8 MS images of 5 pmol AP flowing through the channel on different surfaces. 
(A), (B) The OEG-OTS boundary was aligned with channels in different directions. AP 
signals are visualized in yellow. AP was detected in the channel on the OTS but not on 
the OEG. Signals in the inlet were due to residual peptides left behind when the liquid in 
the reservoir dried out. (C), (D) Comparison of the surface treated with OTS completely 
and the OEF-OTS pattern. AP signals are visualized in rainbow colors, with white 
indicating the highest intensity on the spot, and dark blue the lowest. The OTS chip had 
very strong signals in the reservoir and the OEG-OTS chip had weaker signals there. The 
adsorption length of AP was much longer with OEG-OTS patterning. 
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Figure 3.9 A simple kinetic model describes the molecular adsorption in the microfluidic 
device. (A) An analyte plug (W × L × H) flows through a microchannel with liner 
velocity of v. The channel is divided into multiple segments where the analytes in the 
solution are consumed by adsorption. (B) The adsorption length of analytes increases 
with the amount. (C) The adsorption length is insensitive to a wide range of kA. (D) 
Collection efficiency decreases at high flow rates. (E) The relative timescale between the 
reaction and convection determines the sensitivity of adsorption length to flow rates. (F–
G) Analytes with sufficiently different adsorption rate constants can be separated by the 
microchannel. 
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Figure 3.10 Influence of concentration and flow rate on length measurements. A 
microfluidic device with a straight channel (200 µm width × 50 µm height × 30 mm 
length) was used. The concentrations of 1 and 0.5 pmol/μL were compared with the 
sample amount of 3 pmol AP, and the flow rates of 0.1 and 0.05 μL/min were compared 
with 4 pmol AP. Yellow color indicates the presence of AP. In both cases, the measured 
lengths are insensitive to the changing parameter. 
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Figure 3.11 Reproducibility of quantitation approach in different devices. The 
experiment with 10 pmol AP was repeated in 3 devices. Yellow color indicates the 
presence of AP. The length of yellow band remains essentially constant between different 
devices. 
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Figure 3.12 Characterization of AP peptide via MS imaging of the microfluidic device 
substrate. (A) A series of MS images of the adsorption of 1, 3, 5, 10, and 15 pmol of AP. 
Each spot where AP is detected is colored yellow. (B) Representative mass spectrum 
showing AP. (C) The calibration curve of adsorption length versus amount of AP 
obtained using the observed length from the MS image. Error bars represent s.e.m. 
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Figure 3.13 Intensity profile of 10 pmol AP along the channel. The red line was drawn 
for guidance purpose only. The coverage is saturated along the majority of the band 
expect the partial coverage at the end. This trend is consistent with the prediction from 
the mathematical model shown in Fig. 3.9. 
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Figure 3.14 MS imaging of two peptides (AP and αBCP) from the microfluidic substrate. 
(A) A series of MS images of the adsorption of 1, 3, 5, 10, and 15 pmol of αBCP and 3 
pmol AP. Yellow color indicates AP and green, αBCP. (B) Representative mass spectra 
for the AP and αBCP bands, respectively. (C) The calibration curve of adsorption length 
versus amount for αBCP. Error bars represent s.e.m.  
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Figure 3.15 Comparison of MS images with AP alone and with the coexistence of AP 
and αBCP. In the two images in each row, the amount of AP was the same (1, 3, or 5 
pmol) and the amount of αBCP added was fixed at 3 pmol. Yellow color indicates AP 
and green, αBCP. 
100 
 
 
Figure 3.16 Aplysia bag cell release experiments with the microfluidic device. (A) 
Micrograph of the sample chamber showing the 15 neurons loaded into the inlet reservoir. 
(B) MS image for collection of peptide release when no stimulant was added. (C) MS 
image after neurons were treated with elevated KCl (final concentration = 55 mM). 
Yellow indicates AP and green, αBCP. (D) Representative mass spectra for the control, 
and for the AP and αBCP bands from the release experiments, respectively. 
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CHAPTER 4 
 
COMPARTMENTALIZED DEVICE FOR CONTROLLING AND SAMPLING 
SUBCELLULAR MICROENVIRONMENTS SURROUNDING NEURONS 
 
 
4.1 Notes and Acknowledgements 
 This chapter describes a compartmentalized microfluidic device that can 
accommodate cultured neurons in the microchannel and isolate cell bodies (somata) and 
neurites. The overarching goal of this project is to develop microanalytical platforms that 
can define and sample the chemical microenvironments surrounding small areas down to 
subcellular regions of individual neurons in a neuronal network. Knowledge of the full 
complements of signaling molecules and trophic factors should help understand neuronal 
network formation and neuron damage recovery and even provide clues to potential 
treatments for neurodegenerative diseases. This project involves collaboration with Prof. 
Martha U. Gillett‟s group and Prof. Ralph G. Nuzzo‟s group at UIUC. This work was 
supported by the W. M. Keck Foundation, the National Science Foundation, Award No. 
DMI-0328162, the National Institute on Drug Abuse, Award No. P30DA018310, and the 
National Institute of Neurological Disease and Stroke, Award No. R01NS031609. 
 
4.2 Introduction 
 In the nervous system, the processes of neurons extent over long distances and 
through different extracellular environments to form complex highly-branched networks. 
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The chemical environment surrounding a neuron, varying at the subcellular level (e.g. 
distinct areas of soma and processes of a neuron), affects the response of the neuron to 
chemical or electrical stimulation. Therefore, in order to gain reliable insights into 
signaling molecules in a neuronal network, it is important to mimic this in vivo situation 
and have culture platforms that separate control of the microenvironments of neurites and 
soma. In addition, it has been shown that distinct vesicles of neuropeptides are segregated 
into different terminal sites.
1-3
 For example, in Aplysia bag cell neurons, the 
neuropeptides derived from the amino-terminal and carboxyl-terminal of the egg laying 
(ELH) prohormone are targeted to different processes
1
 and are released from different 
locations
4
. Local release of different signals from the same cell may be important for 
creating complex physiology from simple networks. Therefore, it is necessary to have 
microanalytical platforms that are able to collect local peptide release from specific parts 
of neurons. However, the microfluidic devices described in Chapter 2 and 3 place entire 
neurons in a relatively large volume reservoir or introduce them into a single channel, 
thus not being able to selectively control the environments surrounding sub-regions of 
individual neurons or to allow analysis of local chemical signals. 
 Because of the small size, microfluidics is well suited for manipulating and 
monitoring extracellular microenvironments. This can be achieved by utilizing laminar 
flows in the microchannels.
5, 6
 As the flow in a micron scale channel is laminar, different 
molecules mix by diffusion only. Therefore, a reagent can be specifically targeted to a 
certain area of individual cells, allowing control of subcellular environments. But as the 
neurites from cultured neurons can grow in various directions with regard to the channel, 
it is not always easy to direct the reagent to the area of interest. Also with laminar flows, 
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sampling environments of subcellular regions can be difficult to achieve with high spatial 
resolution. 
 Alternatively, physical barriers can be added to microfluidic devices to isolate one 
part of a neuron from others.
7-9
 In fact, in vitro studies have employed Campenot 
chambers to isolate axons from other parts of neurons.
10
 In this chamber, a Teflon divider 
is attached to a petri dish with a thin silicon grease layer to form two compartments. 
Processes of neurons placed in one side of the divider can be grown to penetrate the 
grease layer into the other side, and the grease serves as a hydrophobic barrier that 
prohibits substantial mixing of liquids in the two compartments. Campenot chambers 
have contributed significantly to axonal biology studies.
11-13
 However, the imperfect 
silicon grease seal can lead to leaking, and even a slight mechanical force could damage 
the neurites. Microfluidics can overcome these challenges. In one culture platform, two 
parallel main channels with much larger dimensions were connected with a large number 
of small-diameter microgrooves. These microgrooves were used as the physical barrier 
and their high fluidic resistance provided a good isolation of these two main channels. A 
relatively large number of neurons (about 3000 cells) were loaded into one of the main 
channels, and after culture, the axons projected from the neurons were guided through the 
small connections into the other channel. The device was divided into a somal and an 
axonal side; either side could be separately manipulated.
7
 In fact, this 
polydimethylsiloxane (PDMS) device has been commercialized (from Xona 
Microfluidics, LLC), but only a few formats are offered for sale.   
 In this study, we changed the channel width and depth of the compartmentalized 
device mentioned above according to the size of Aplysia neurons. We used smaller 
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reservoir and channel sizes to facilitate studies on small number of cells down to single 
neurons. The design of the device was also modified. Here it contains three parallel 
channels; cells are loaded into the middle main channel and the two secondary channels 
accommodate the outgrown neurites. Local releasate from different terminals can be 
sampled and compared to each other. The device was also adjusted to be better interfaced 
to the sample collection method described in the previous chapters. Because of the lower 
density of cells and more compact space, cell culture in microchannels presented 
challenges. We addressed these challenges with introduction of perfusion flow and 
solvent extraction of PDMS
14
. 
 
4.3 Experimental 
Appendix A contains a master list of all abbreviations used in this chapter. 
4.3.1 Materials and Reagents 
Unless noted otherwise, all chemicals were purchased from Sigma-Aldrich (St. 
Louis, MO) and organic solvents were from Fisher Scientific (Fair Lawn, NJ). The 
PDMS prepolymer kit, Sylgard 184, was purchased from Dow Corning (Midland, MI). 
Silicon wafers were obtained from WRS Materials (Spring City, PA). Photoresist SU-8 
and developer were from MicroChem Corp (Newtown, MA). Trideca-fluoro-1,1,2,2,-
tetrahydrooctyl trichlorosilane was obtained from Gelest (Morrisville, PA). Glass 
coverslips (22 mm × 40 mm, No. 1 thickness) were from Corning (Product #: 2935-224, 
Corning, NY). The culture media for Aplysia bag cell neurons were made by 
supplementing artificial sea water (ASW) with antibiotics (final concentrations of 67.7 
mg/L penicillin G, 100 mg/L streptomycin, and 50 mg/L gentamicin) and nutrients (final 
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concentrations of 1.1 g/L D-glucose, 0.3 g/L L-glutamine, and 0.1 g/L L-methionine). 
ASW (pH 7.8) contained 460 mM NaCl, 10 mM KCl, 10 mM CaCl2, 22 mM MgCl2, 26 
mM MgSO4, 2.5 mM NaHCO3, and 15 mM HEPES. 
 
4.3.2 Glass Surface Treatment 
 To facilitate observation of cells in the channels, glass coverslips were used as the 
substrates for the compartmentalized device. Glass coverslips were cleaned with 
methanol and water sequentially, and dried with nitrogen. Coverslips were then dipped 
into 1% (v/v) H2SO4 for at least 3 h to remove the metals doped in glass which might be 
toxic to neurons. Each coverslip was then covered with 1 mL 0.1% (v/v) poly-L-lysine 
(PLL) solution for 2 h and then rinsed with DI water 3 times to remove extra PLL. The 
PLL-coated coverslips were stored in the 4 °C refrigerator until use. 
 Alternatively, a pattern containing repeated straight lines of PLL and bovine 
serum albumin (BSA) was coated on the surface of glass. A PDMS piece with an array of 
parallel straight channels (Fig. 4.1, channel width: 50 or 100 µm, edge-to-edge spacing: 
50 or 100 µm) was placed on top of a glass coverslip. Each channel was then filled with 
0.1% (v/v) PLL solution according to the procedure of channel outgas technique reported 
previously
15
. A PDMS extension reservoir was added onto the top of the inlet reservoir to 
enable holding larger volume of filling solution. About 200 µL PLL solution was added 
to the extension reservoir and the whole device was put into a vacuum desiccator for 10 
min so that PLL could fill all the channels without substantial air bubbles. The device 
was then removed from vacuum and placed in the ambient condition for 2 h. After that, 
the PLL solution in the reservoirs and channels was removed with vacuum as much as 
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possible and then DI water was flushed through the channels twice to wash away 
unattached PLL. The PDMS top was peeled off from the glass substrate afterwards. BSA 
was diluted to a 0.1 % v/v solution and was used to cover the glass substrate partially 
coated with PLL for another 2 h. After that, the substrate was rinsed with DI water and 
dried with nitrogen. The coated coverslips were stored in the 4 °C refrigerator until use. 
 
4.3.3 Device Fabrication 
 Fabrication of the compartmentalized device consisted of two steps of 
photolithography and development, due to different heights of interconnects (3 µm high) 
and main/secondary channels (70 µm high). In order to ensure a good adhesion of small 
photoresist features to the silicon wafer, the wafer was first cleaned thoroughly with 
piranha solution (3:1 H2SO4:H2O2, Caution! Piranha is a strong oxidant. It reacts 
aggressively with organic materials and should be handled with great care). The silicon 
wafer was then rinsed with large amount of DI water and dried with nitrogen. After that, 
SU-8 2002 was spin-coated onto silicon to form a layer of 3 μm thick, and then exposed 
to UV light through the first mask containing high density of straight lines. Following 
development, a SU-8 pattern with interconnects was formed on the wafer. Subsequently, 
a second layer of SU-8 2075 (70 μm thick) was coated onto the silicon wafer. Before 
photolithography, the second mask containing the main/secondary channels was aligned 
against the interconnects on the wafer so that they intersected close to the middle of the 
main channel at almost 90°. After the second step of UV exposure and development, the 
master with the pattern of an entire compartmentalized device was made. This process is 
illustrated in Fig. 4.2. PDMS devices were made by molding Sylgard 184 onto the master. 
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To help release cured PDMS from the master, especially at the area of high-density small 
interconnects, the master was first treated with trideca-fluoro-1,1,2,2,-tetrahydrooctyl 
trichlorosilane by placing the master with 2-3 drops of the silanizing agent in an open 
dish together in a desiccator for 2 h. The PDMS prepolymer was then poured onto the 
master and cured at 70 °C overnight. The reservoirs were made with an AcuPunch 
(Acuderm, Inc., Ft. Lauderdale, FL) biopsy punch of 2 mm diameter.  
 
4.3.4 Solvent Extraction of PDMS 
 The extraction procedure was modified from previous reports
14, 16
. Sequentially, 
PDMS pieces were immersed into pentane for 36 h, new pentane 7 h, xylenes 16 h, new 
xylenes 7 h, ethanol 16 h, another ethanol for 7 h, and finally DI water overnight, with 
continuous stirring. One PDMS piece required 100 mL of each solvent. After extraction, 
PDMS was dried at 70 °C overnight. Extracted PDMS was stored in the ambient 
condition until use. 
 
4.3.5 Neuron Isolation and Loading 
 Aplysia californica were anesthetized by injection of magnesium chloride (50% of 
body weight) into the body cavity. Individual bag neurons were isolated after incubation 
in ASW with proteases (1% type IX and 1% type XIV) at 35 °C for 90 min as described 
in previous chapters. The cells were then introduced into the microchannel, which was 
prefilled with culture media for bag cell neurons. During the loading process, the 
microfluidic device was kept on the stage of an inverted microscope (Zeiss Axiovert 25) 
so that the movement of cells in the channel could be monitored. An ASW solution 
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containing about 20 cells was loaded into the inlet reservoir of the main channel, and an 
Eppendorf pipette immediately applied a negative pressure at the outlet. When the cells 
entered into the channel, as monitored by the microscope, the pipette was removed at 
once and another pipette was used to add to the outlet the amount of culture media equal 
to the volume of solution at the inlet to stop the flow. After loading, the cells in the 
channel were allowed at least 1 h to attach to the bottom glass surface. 
 
4.3.6 Culturing Neurons inside Microchannels 
 The tip end of a 200 μL Pipette tip was cut off with a razor, and the flat end was 
glued with silicon grease on top of the reservoir hole to enlarge its holding volume. After 
that, equal amounts of culture media (about 200 μL) were used to fill the extended inlets 
and outlets of the main and secondary channels. 20 μL of media was added into the inlet 
reservoir to introduce a perfusion flow through the channel from inlet to outlet. Parafilm 
M (Bemis Flexible Packaging, Neenah, WI) was cut into small pieces and attached to the 
open ends of reservoir extensions to reduce evaporation of media during culturing. The 
whole device loaded with neurons was then placed in an incubator maintained at 14 °C. 
To further reduce evaporation, small dishes of water were placed near the device. The 
device was replenished with fresh media every 24 h. The growth of neurons inside the 
microchannel was monitored with the Zeiss inverted microscope.  
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4.4 Results and Discussion 
4.4.1 Device Design 
 The compartmentalized device contains one main channel (100 or 200 μm wide, 
70 μm high, 20 mm long) and two parallel secondary channels (50 or 100 μm wide, 70 
μm high, 15 mm in the middle segment). The edge-to-edge spacing between adjacent 
channels is 50 or 100 μm. The small channels connecting secondary channels to the main 
channel have the width of 3 μm, height of 3 μm, length of 2 mm, and center-to-center 
spacing of 10 μm. Because the main/secondary channels are much taller than the 
interconnects, fabrication of this device was performed in two steps of photolithography 
and development. The chip was designed in such a way that under appropriate conditions, 
the processes sprouted from neurons placed in the main channel could penetrate the small 
interconnects to enter into the adjacent secondary channels. The use of glass substrates 
here permits continuous monitoring of neurons in the microchannel. The design and 
picture of this microfluidic device is shown in Fig. 4.3.  
 
4.4.2 Controlling Flows in Individual Microchannels 
 The compartmentalized device allows isolation of somata and neurites of neurons, 
and manipulation and sampling of each subcellular region. In order for this device to be 
feasible, the fluidic environment in each channel should be able to be controlled 
individually. The small dimensions of interconnects significantly reduced the liquid flow 
between large channels with high flow resistance. To counteract diffusion between 
adjacent channels, a hydrostatic pressure difference was established by adding slightly 
more liquid into the reservoirs of channels other than the one whose flow needed to be 
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separately controlled. For example, if the fluidic environment in one secondary channel 
needed to be isolated, 2 μL more solution was added into the middle main channel and 
the other secondary channel, as illustrated in Fig. 4.4A. The higher hydrostatic pressures 
at these two channels introduced a very slow flow inside the interconnects to the channel 
to be isolated, which canceled out the diffusion from that channel. This was visualized by 
a blue ink solution introduced in the left channel in Fig. 4.4A. With the hydrostatic 
pressure difference, the blue ink was confined into the left channel. No blue color was 
visible from the middle or right channel. The isolation of left channel was further 
confirmed with MALDI MS, which provided more sensitive detection. 5 pmol of a 
standard peptide, angiotensin II was added into the inlet of the left secondary channel. 
After 2 h, 1 μL of the solutions from the outlets of the left and middle channel were 
deposited to a MTP 384 polished steel target plate (Part No. 209520, Bruker Daltonics, 
Bremen, Germany). 1 μL 2,5-dihydroxybenzoic acid solution (DHB, 10 mg/mL in 
50%/50% acetonitrile/water) was added to each spot to mix with the sample. The MALDI 
spectra are shown in Fig. 4.4B, which clearly demonstrates that the angiotensin II peaks 
were only detected from the left but not the middle channel. Given the high sensitivity of 
MALDI, no significant mixing of fluids in adjacent channels occurred during this time 
period. Based on the same principle, the middle main channel could also be specifically 
controlled by adding more liquids into the two secondary channels. As shown in Fig. 
4.4C, the yellow color was restricted to the middle channel. 
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4.4.3 Introducing Neurons into Microchannel 
 Loading neurons into the microchannel presents challenges. After adding the cell 
solution into the inlet, a hydrostatic flow occurs due to the higher level of liquid in the 
inlet than the outlet. But by using gravity flow alone, the bag cell neurons attached in the 
reservoir instead. Cells could be moved by applying vacuum at the outlet with tubing 
connected to the vacuum line. However, the force was too fast as they were quickly 
drawn to the outlet, without leaving enough time to allow them to attach on the substrate. 
A narrower segment (25 µm wide) of channel was added near the outlet as an attempt to 
capture the cells (Fig. 4.5A). But with the force of applied vacuum, the cells could be still 
squeezed through the narrow restriction and some cells were lysed. Alternatively, a 
sharpened needle could be used to punch a hole near the middle of the main channel with 
the diameter of about 300 μm (Fig. 4.5B). Cells could then be placed into this open 
access hole without the need to introduce flow in the channel. But such a hole was too 
large and easily disrupted the adjacent secondary channels. Besides, it caused disturbance 
in the flow, leading to undesirable results during flow control. 
 The most reliable way to load neurons so far was achieved by using a pipette to 
draw the cell solution through the channel. The drawing force by the pipette was more 
controllable than vacuum, allowing cells to move slower and leaving enough time to stop 
them inside the channel. Glass beads with diameter of 40 μm, about the size of bag cell 
neurons, could be used here for practice purposes. After the beads or cells were entering 
the channel from the inlet, the pipette used to pull the solution was stopped immediately, 
and another pipette was used to add certain amount of culture media to the outlet to make 
the liquid levels in the outlet and inlet the same. After that, neurons gradually stopped 
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moving and started attaching onto the glass substrate. One example of an attached neuron 
is shown in Fig. 4.6A. Cells were kept undisturbed for at least 1 h to allow good 
attachment to the substrate, which was crucial to neuronal growth. With this approach, 
however, there were still many neurons adsorbed onto the inlet (Fig. 4.6B). 
 
4.4.4 Increasing Neuron Viability inside Microchannels 
 Aplysia bag cell neurons are generally easy to culture on the open dish. Under 
appropriate conditions (14 °C), they can be grown on different surfaces. Bag cells have 
been successfully grown on a culture dish (Falcon, Franklin Lakes, NJ), PLL-coated glass 
coverslip, bare silicon, silicon modified with octadecyltrichlorosilane (OTS), silicon 
modified with 2-[methoxy(polyethyleneoxy)propyl]trimethoxysilane (OEG), and PDMS 
(Fig. 4.7). The protocol for silicon derivatization was described in Chapter 2 and 3.  
 However, the environment in the microchannel is quite different from the open 
dish. In an open dish, both diffusion and convection help maintain a homogeneous 
chemical environment throughout the media, continually providing cultured neurons with 
a fresh supply of nutrients and diluting waste secretion from the cells quickly. In contrast, 
due to the small size of microchannel, only diffusion can occur in this confined space. 
After neurons consume the nutrients proximal to them, they have limited access to fresh 
media because of the slow diffusion of nutrient molecules. Also the waste secreted from 
neurons would accumulate surrounding them, which appears toxic for cell growth. 
Therefore, a local microenvironment is created that is not amenable to culturing 
neurons.
17
 Another issue specifically with PDMS devices is PDMS itself. Although 
PDMS is generally biocompatible and gas-permeable, the untreated PDMS can absorb 
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nutrient molecules from the media, and oligomers and the platinum-containing catalyst 
used for curing PDMS, which are unhealthy for neuronal growth, can leach into the 
media.
14, 18
 This issue becomes more significant as the surface-to-volume ratio increases 
with smaller channels. Because of these two reasons, bag cell neurons did not grow after 
several days of culture in the preliminary tests (Fig. 4.8A). 
 To overcome the challenges within local microenvironments, a gravity-induced 
perfusion flow was introduced into the system to continuously supply the neurons with 
fresh media. It was realized by adding more liquid into the inlet of a channel, causing a 
steady flow from the inlet to the outlet. Reservoir extension made from pipette tips was 
used to hold more media. Every 24 h, the liquid level difference was reestablished with 
fresh media. To solve the issue with PDMS, before assembling the device, PDMS was 
subject to serial solvent extraction. The extraction has been demonstrated to effectively 
remove the uncrosslinked oligomers and platinum catalyst.
14
 After these additional 
treatments, about 1 out of 3 bag cell neurons grew well even after several days of culture. 
One example is shown in Fig. 4.8B. 
 
4.4.5 Patterning Glass Surfaces with PLL/BSA for Guidance of Neuronal Growth 
 Fig. 4.8B also shows that the neurons preferred to grow along the channel instead 
of penetrating the interconnection channels. It was likely due to the highly restricted 
space of the small interconnects. In order to guide the neuronal growth through 
interconnects, the surface chemistry of glass needed to be modified to provide chemical 
cues for directing process outgrowth. We previously reported that neuronal growth 
aligned well with a pattern of repeated lines of PLL and BSA.
19
 Here, we used a PDMS 
117 
 
device containing a large number of parallel straight channels (Fig. 4.2) to deposit PLL 
lines onto the glass surface; the remaining bare glass was then coated with BSA. It was 
difficult to fill all the parallel channels without introduction of significant air bubbles by 
applying vacuum at the outlet reservoir. Instead, a reservoir extension was added onto the 
inlet which could hold more PLL filling solution, and the whole device was placed under 
vacuum, according to the channel outgas technique procedure reported previously
15
. 
Fluorescein isothiocyanate (FITC)-labeled PLL was used here to visualize the liquid 
inside the microchannels with a Zeiss FluoArc fluorescence microscope, as shown in Fig. 
4.9A. The image clearly indicates that all the channels were filled with FITC-PLL 
solution without substantial air bubbles. Fluorescence images of the glass substrate after 
coating also showed PLL lines (Fig. 4.9B), indicating that PLL adsorbed to the glass. 
Future work will be applying this surface patterning technique to the compartmentalized 
device to guide neuronal growth into the small interconnects. 
 
4.5 Conclusions 
 Microfluidics allows control and sampling of chemical environments surrounding 
subcellular regions of individual cells. In a commercially available compartmentalized 
neuron culture platform, neurites from neurons can enter into a different channel from the 
somal channel so that the environments surrounding somata and neurites can be 
separately manipulated. Here we tailored the device to the cell sizes under investigation. 
We modified the chip design to include one main channel for somata and two secondary 
channels for processes, which are connected with small interconnects. In this way, the 
releasate from different terminals can be sampled separately and compared. With an 
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established hydrostatic pressure difference, each large channel could be fluidically 
separated from adjacent ones in this three-channel system. The challenges of culturing 
cells inside microchannels were addressed with introduction of a perfusion flow and 
PDMS extraction with serial solvents. A pattern of PLL/BSA was fabricated, which can 
guide the direction of process outgrowth. Future work includes combing this surface 
patterning technique with the compartmentalized microfluidic device to guide the 
neurites through the innterconects, and interface the sample collection method described 
previously to this device to sample local peptide release from each part of a single neuron. 
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4.6 Figures 
 
 
 
 
 
Figure 4.1 Mask design of the device used to pattern glass with repeated lines of PLL 
and BSA. Channels (transparent part on the mask) were filled with PLL. The width of 
channels was both 50 and 100 µm, and the edge-to-edge spacing was 50 and 100 µm. 
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Figure 4.2 Fabrication process of compartmentalized microfluidic device. The blue color 
indicates photoresist. The process involves two steps of photolithography and 
development.  
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Figure 4.3 Design of compartmentalized microfluidic device. (A) Masks for the 
main/secondary channels and the interconnects. Individual feature sizes are listed.  (B) A 
cartoon shows that the processes from a neuron penetrate the interconnects into the 
secondary channels. In this way, the processes and soma of a neuron can be separated. (C) 
A picture of the assembled compartmentalized PDMS device. 
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Figure 4.4 Controlling flows in individual channels. (A) Isolation of the left channel is 
visualized by blue ink. It was achieved by adding more liquids into the middle and right 
channels. (B) Confirmation of fluidic isolation in the left channel with MALDI MS. The 
liquid levels in each channel were the same as (A). After angiotensin II was added into 
the left channel, its signals could only detected from the left (1) but not the middle 
channel (2). (C) Isolation of the middle channel is visualized by yellow ink. It was 
achieved by adding more liquids into the left and right channels. 
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Figure 4.5 Loading neurons into microchannel. (A) A narrow segment of channel (25 μm 
wide) was added near the outlet to capture the moving neurons. (B)  An open hole was 
punched near the middle of the main channel for loading cells. Note glass beads 
(diameter of 40 μm) were used here as a substitute for cells. 
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Figure 4.6 Loading neurons into microchannels with pipette. (A) A neuron was attached 
in the channel. (B) Many neurons attached in the reservoir instead of in the channel. The 
white arrows indicate the bag cells neurons.  
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Figure 4.7 Growth of Aplysia bag cell neurons on different surfaces. (A) Culture dish, (B) 
PLL-coated glass coverslip, (C) bare silicon surface, (D) OTS-modified silicon surface, 
(E) OEG-modified silicon surface, and (F) PDMS layer. 
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Figure 4.8 Culturing Aplysia bag cell neurons in microchannels. (A) Preliminary result 
after 3 days of culture, with native PDMS and no perfusion flow.  (B) Neurons grew well 
after 3 days of culture, with extracted PDMS and perfusion flow. 
 
 
 
127 
 
 
 
 
 
Figure 4.9 Patterning PLL/BSA lines on glass. (A) FITC-PLL solution filled the parallel 
channels without significant air bubbles. (B) Fluorescent image of PLL lines after PLL 
coating. The high background was due to ambient light. 
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CHAPTER 5 
 
CONCLUSIONS AND FUTURE WORK 
 
 
 Deciphering the chemical signals in the nervous system is an important but 
challenging task. The main objective of this dissertation is the development of analytical 
platforms by coupling microfluidics to mass spectrometry to define and sample the 
chemical microenvironments surrounding small number of neurons. Microfluidic 
technology is well suited for studying mass-limited samples and controlling local 
environments. On the other hand, mass spectrometry (MS) offers high information 
content about analytes of interest without the need for prelabeling or preselection, serving 
as an excellent detection method for the samples collected within microfluidic devices. 
The specific group of chemical signals we investigated in this work is neuropeptides. 
However, the microfluidic systems and the detection scheme we developed here could be 
adapted to many other molecular classes.  
 Chapter 2
1
 presented our interface of microfluidic devices and matrix-assisted 
laser desorption/ionization (MALDI)-MS imaging by using the substrate of the device 
directly as the MALDI target. The substrate was modified with octadecyltrichlorosilane 
(OTS) so that the surface resembled the C18 material used in liquid chromatography 
systems. The modified surface was able to collect the peptide molecules in the solution 
flowing down the channel by hydrophobic interaction; different molecules were separated 
on the surface due to different adsorption capability. This surface modification method 
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was demonstrated to be the optimal choice for collecting peptides by comparison to the 
surfaces derivatized with other chemicals in terms of sampling efficiency. The 
microfluidic device was dissembled after sample collection, and the substrate was 
directly introduced into the mass spectrometer for imaging after application of a matrix 
layer. This sampling and detection scheme is simple and adaptable to different 
applications; the sampling area can be fabricated at different locations of the chip with 
surface patterning techniques. The substrate used can be silicon or glass; in the case of 
glass, a layer of gold needs to be deposited on the surface to increase conductivity. The 
capability of the modified surface to adsorb peptides was independently confirmed by 
measurements of a captured radiolabeled peptide after the peptide solution flowed on top 
of the surface.  
In Chapter 2, we also demonstrated different polydimethylsiloxane (PDMS) 
microfluidic devices used to investigate peptide release from neurons. We developed a 
device that contained an inlet reservoir connected to three branches of channels. A small 
number of Aplysia bag cell neurons were loaded into the inlet and were chemically 
stimulated to trigger peptide release. A negative pressure was sequentially applied to the 
outlet of each channel so that peptide release at different time points could be monitored. 
For example, we demonstrated that the media surrounding the neurons were sampled 
before, during, and after a simulation event; the fact that released peptides from bag cells, 
such as acidic peptide and egg laying hormone, were detected mainly in the “during” 
channel confirmed that the secretion of peptides was indeed due to the chemical 
simulation. In another device used for single cell analysis, one single neuron was loaded 
into a microchannel, and the released peptides in response to stimulation were collected 
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onto the sampling area of a C18-coated gold strip deposited down the channel. Before the 
sampling area, the cell loading channel was split into three branches, which were used to 
sample the microenvironment around the neuron before, during, and after simulation. Of 
course, more channel branches can be added to both chip designs, so that the device can 
be used to investigate the event of peptide release at greater temporal resolution. A 
microfluidic device containing an inlet reservoir and one long serpentine channel was 
designed to study the surface coverage of standard peptides. One intriguing result from 
these experiments was that a peptide, either angiotensin II or substance P, would be 
depleted before the surface was saturated; the length of the channel covered by a peptide 
increased with its amount. This result indicated that this device could be potentially used 
for quantifying the amount of released peptides, the basis of the follow-up work in 
Chapter 3. The applicability of the devices shown in this chapter clearly demonstrates 
that an efficient combination of microfluidics and mass spectrometry can be used for 
studying the small amount of peptides released, with the sensitivity allowing for single 
cell measurements.  
A unique method to quantify peptides based on the adsorption length was 
described in details in Chapter 3.
2
 We improved the microfluidic device with the 
serpentine channel mentioned in Chapter 2; here the outlet tubing was embedded into 
PDMS, ensuring a good seal at the outlet and a stable flow. The flow rate could now be 
precisely controlled by a syringe pump. The reservoir size was also optimized; the 
diameter of 1.5 mm was chosen to minimize sample loss to the reservoir while permitting 
easy liquid handling and cell loading. Most importantly, the issue of sample loss to the 
inlet reservoir and PDMS were addressed by oligo(ethylene glycol) (OEG) coating, 
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enabling more reliable and consistent quantitation results. Scintillation measurements of 
radiolabeled angiotensin II after incubated in PDMS channels showed that the OEG 
treatment of PDMS significantly increased the peptide recovery to more than 70% from 
about 50% with native, plasma-treated, or solvent-extracted PDMS. The nonspecific 
adsorption of peptides inside the reservoir was also reduced by derivatizing that area with 
an OEG-containing silane; the adsorption length of the same amount peptide was 
significantly longer than that on the surface completely coated with OTS. The OEG 
silanization reaction is a simple and effective way to make part of the substrate resistant 
to peptide adsorption, as compared to other surface patterning methods including 
deprivation of the OTS layer in the reservoir with oxygen plasma, partially coating the 
substrate with OTS, and the use of OEG-thiol on gold that was deposited on the reservoir 
area. In addition to the device enhancement, a mathematical model was proposed to 
describe the adsorption processes in the microchannel. The model was based on the 
kinetics of a simple adsorption reaction for a single peptide, and competitive adsorption 
of multiple peptides determined by adsorption rate constants. It predicted the linear 
correlation between the adsorption length and the amount of an analyte, and separation of 
multiple peptides by the channel. The model also examined the influence of experimental 
parameters and found that the adsorption length was insensitive to concentration and flow 
rate as long as the time scale of the flow was larger than that of the adsorption reaction. 
The conclusions from the model supported our quantitation method and were confirmed 
by the validation experiments. The test on 1 to 15 pmol acidic peptide showed a good 
linearity between length and amount (R
2
 = 0.97). When both acidic peptide and α-bag 
cell peptide were present, these two peptides were separated in the channel and the linear 
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relationship still maintained for individual peptides (R
2
 = 0.98 for 1 - 15 pmol α-bag cell 
peptide). The adsorption length of a peptide in a mixture remained the same to that of the 
same amount peptide when it was alone. The variance of length measurements, defined 
as the ratio of standard error of the mean to mean, was achieved as low as 3% between 
devices. By applying this quantitation approach on 15 chemically stimulated Aplysia bag 
cells, we detected two distinct bands of acidic peptide and α-bag cell peptide. The 
amounts of peptides released from one single neuron were determined to be 0.15 ± 0.03 
pmol of acidic peptide and 0.13 ± 0.06 pmol of α-bag cell peptide, which matched 
measures from other methods. Our quantitation method based on adsorption length 
proved to be a simple, label-free, and robust way to quantify mass-limited analytes in 
microfluidic devices. 
 Chapter 4 demonstrated a compartmentalized PDMS microfluidic device that 
could separate one part of a neuron from the others, enabling spatial analysis of local 
chemical signals. The design was based on a commercially available device
3
, which we 
modified according to the sizes of Aplysia neurons under investigation. The device 
contained one main cell loading channel and two adjacent secondary channels; they were 
connected by small interconnection channels. Under appropriate conditions, the neurites 
from the neurons could go through the interconnects to the secondary channels. 
Fabrication of this device involved two photolithography steps, sequentially making the 
features of the interconnects and the main/secondary channels on the wafer. We 
demonstrated that the liquid environment in each channel could be separately controlled 
by establishing a hydrostatic pressure difference between adjacent channels. The most 
efficient way for loading cells into the microchannel was by applying a pipette at the 
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outlet to draw the cell solution into the channel and then instantly stopping the pipette 
when some cells were inside. To increase the cell viability inside the microchannel, a 
perfusion flow was introduced into the system and the PDMS piece was extracted with 
serial solvents. We also found it necessary to pattern the substrate with repeated lines of 
poly-L-lysine and bovine serum albumin to guide the direction of process outgrowth from 
the neurons, so that the processes would penetrate the interconnects; otherwise the 
processes would follow the flow direction in the main channel. The pattern was made by 
introducing the poly-L-lysine solution through a device with a large number of parallel 
straight channels placed on top of the substrate, and then coating the substrate with poly-
L-lysine lines with bovine serum albumin to fill the spaces between these lines. The 
success of pattern fabrication was confirmed by visualizing the surface with fluorescently 
labeled poly-L-lysine.  
As for the future work, we will continue working on the compartmentalized 
device mentioned in Chapter 4 by applying the poly-L-lysine/bovine serum albumin 
pattern to cell culturing in the device. The culture conditions may need to be optimized to 
ensure that the outgrown neurites go through the interconnects and reach the adjacent 
channels, especially when there are only few to even single cells in the device. After the 
guided cell culture is achieved, we will use suitable collection methods to sample the 
subcellular environments of neurons. One promising method is to utilize the derivatized 
surface as in the previous devices. But as the substrate of the compartmentalized device is 
glass, for the sake of microscopic monitoring, the surface modification process used for 
the signal cell analysis chip in Chapter 2 will be adapted here. Briefly, a gold strip is 
deposited on the glass substrate, and then the self-assembled monolayer of 
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octadecanethiol is coated on the gold. In the assembled device, the gold strip is located 
downstream to where cells are to be attached; the releasate from the cells is captured by 
the thiolated surface. 
While quantitation of released peptides during a single event is important, 
sometimes it is of more interest to be able to compare the components and quantities of 
releasate from the same neurons at different time points, in response to various chemical 
cues, or under different physiological conditions. Future work in this subject is based on 
the accomplishments described in Chapter 2 and 3. For this purpose, the serpentine 
channel design will be combined to the branching channels, one example shown in Fig. 
5.1A. In this device, neurons are loaded into the inlet reservoir, and for instance, they can 
be treated with elevated potassium chloride, serotonin, and insulin sequentially. Each 
time after the chemical stimulation, the media surrounding the cells will be drawn into 
one of the channels with a syringe pump, and then the cells will be reconditioned with 
fresh media. The MALDI imaging profiles from the channels can be compared to each 
other. The device of this type offers flexibility in the chip design; more collection 
channels can be added if more conditions need to be compared or the release event needs 
to be monitored at greater temporal resolution. To eliminate the crosstalk between 
branching channels, a valve system can be applied to the device. In one valve system, a 
gas channel is placed on top of the fluidic channel and a thin PDMS membrane is 
sandwiched between these two channels.
4
 The membrane can block or unblock the fluidic 
channel, which is controlled by the air pressure of the gas channel. The air pressure is 
adjusted by 3-way solenoid valves that can be easily interfaced to a computer for 
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controlling. The work on the valve system is currently underway by Callie Croushore and 
Dr. Chang Young Lee in our group.  
To gain knowledge of the important chemical signals during neuronal network 
formation and neuron damage recovery, it is necessary to develop microfluidic devices 
that can monitor the neuronal wiring or regeneration within the device and sample the 
local chemical environments during the event. Fig. 5.1B shows one conceptual design of 
this kind device. The device contains five parallel channels connected by small 
interconnection channels, and two neurons (orange in the figure) are loaded into separate 
channels. Under appropriate conditions, the processes from the two neurons go through 
the interconnects into the adjacent channels and make a connection in the middle channel. 
The cell loading channel has a cell capturing chamber, and a small side channel attached 
to it to push a single cell into the capturing structure. Each of the channels can be 
fluidically separated from the others by using the principle of hydrostatic pressure 
discussed in Chapter 4, so that the local environment around the neuronal connection, the 
soma of either cell, and different process terminals can be individually defined and 
sampled. More channels can be added for finer spatial or temporal resolution for analysis. 
Since the amount of sample here is small, the sample collection method and the detection 
scheme need to be optimized for high-sensitivity analysis. 
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5.1 Figures 
 
 
Figure 5.1 Design of microfluidic devices for future work. (A) A device contains three 
branches of serpentine channels. This device can be used for comparison of components 
and quantities of the releasate from neurons at different time points and conditions. (B) A 
device contains multiple channels connected by small interconnects. Two neurons 
(orange) can be loaded into separate channels and the event of neuronal connection or 
regeneration can be monitored. The local microenvironments surrounding the neuronal 
connection and different parts of the neurons can be sampled for studying the important 
chemical signals involved in neuronal network formation and neuron damage recovery. 
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APPENDIX A: LIST OF ABBREVIATIONS 
 
αBCP    α-Bag cell peptide 
Ang II    Angiotensin II 
AP    Acidic peptide 
APTS    (3-Aminopropyl)trimethoxysilane 
ASW    Artificial seawater 
BSA    Bovine serum albumin 
C18    Octadecyl alkyl chains or octadecanethiol 
CD    Compact disk 
CIEF    Capillary isoelectric focusing 
DHB    2,5-Dihydroxybenzoic acid 
DI    Deionized 
DMAPTS   (N,N-Dimethylaminopropyl)trimethoxysilane 
DMOPAC Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium 
chloride 
ELH    Egg laying hormone 
ESI    Electrospray ionization 
FITC    Fluorescein isothiocyanate 
HPLC    High performance liquid chromatography 
m/z    Mass-to-charge ratio 
MALDI   Matrix-assisted laser desorption/ionization 
MS    Mass spectrometry 
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MSI    Mass spectrometry imaging 
ODE    Ordinary differential equation 
OEG    2-[Methoxy(polyethyleneoxy)propyl]trimethoxysilane 
or (11-mercaptoundecyl)tetra(ethylene glycol) 
OTS    Octadecyltrichlorosilane 
PC    Polycarbonate 
PDMS    Poly(dimethylsiloxane) 
PET    Polyethylenerephthalate 
pI    Isoelectric point 
PLL    Poly-L-lysine 
PMMA   Poly(methyl methacrylate) 
ROACHE   Rapid open-access channel electrophoresis 
SAM    Self-assembled monolayer 
s.e.m.    Standard error of the mean 
SNR    Signal-to-noise ratio 
TLC    Thin layer chromatography 
TOF    Time of flight 
UV    Ultraviolet 
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APPENDIX B: FABRICATION PROCESS OF MICROFLUIDIC DEVICES 
 
The negative epoxy-based SU-8 2000 serial photoresists were purchased from 
MicroChem Corp. (Newtown, MA). The detailed fabrication procedure of SU-8 maters, 
used for molding poly(dimethylsiloxane) (PDMS) devices, is based on the datasheets 
found at http://www.microchem.com/Prod-SU82000.htm. First, a 3-inch silicon wafer 
(WRS Materials, Spring City, PA) is cleaned sequentially with acetone, methanol, and DI 
water and is blown dry with nitrogen. It is then placed on a hot plate maintained at 95 °C 
to dehydrate the surface. If fine structures of SU-8 (feature size < 5 μm) are to be 
fabricated, the wafer needs an immersion into piranha solution (H2SO4:H2O2 = 3:1, 
Caution! Piranha is a strong oxidant. It may explode on contact with organic residues) 
for 15 min and a rinse with a large amount of DI water. Piranha significantly removes 
organic contaminants on the silicon surface and ensures that small SU-8 features attach 
firmly to the wafer. The dehydrated wafer is then transferred to a CEE 100 programmable 
spinner that holds the wafer with vacuum. Approximately 5 mL SU-8 is dispensed onto 
the silicon wafer with a plastic dropper to cover the entire surface. Large air bubbles 
trapped in the photoresist should be removed with a new plastic dropper before spin-
coating. The thickness of an SU-8 layer depends on the spin speed and the specific SU-8 
product used, determining the height of structures in the final PDMS device. For instance, 
if a thickness of 10 μm is needed, SU-8 2010 can be used and spin-coated at 3500 rpm. 
Or if 50 μm is needed, SU-8 2050 is chosen and the spin speed is set at 3300 rpm. (Note: 
the relationship of spin speed versus thickness may change depending on the batch of 
products. Always check the protocol posted on the MicroChem website before starting.) 
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The program of spin-coating is usually set as follows: step 1: spinning at 500 rpm for 5 s, 
ramping at 100 rpm/s; step 2: spinning at the desired speed for 30 s, acceleration at 300 
rpm/s. After that, a razor is used to remove the photoresist built up on the edge of the 
wafer. The coated silicon wafer is then put onto a hot plate for a soft bake. The purpose 
of soft bake is for the evolution of solvents and the formation of a uniform film. For a 50 
μm film, the wafer is heated at 65 °C for 1 min and then 95 °C for 7 min. If wrinkles are 
still observable on the wafer after the prescribed time, the time of soft bake can be 
extended. After the soft bake, the wafer is left at room temperature for a sufficient time to 
allow cooling down completely.  
A photolithography mask can be designed with Adobe Illustrator or AutoCAD. It 
can be printed on a transparency by ordering 5080 film production from the Printing 
Department at UIUC (http://www.printing.illinois.edu/L4SpecServ_5080.htm). The 
transparency mask is taped on a glass plate which is then mounted onto the mask holder 
of a Kasper mask aligner. (Note: make sure that the printed side of the mask faces the 
wafer.) The cooled wafer is also placed on the wafer area of the mask aligner and is fixed 
in position with vacuum. After the wafer and the mask have made a firm contact, their 
relative positions can be adjusted by the aligner. The exposure time is calculated by 
dividing the desirable exposure dosage (in mJ/cm
2
) by the intensity of the UV lamp. To 
compensate the light loss due to absorption by the glass plate and the transparency, the 
practical exposure dosage usually doubles the recommended one in the SU-8 datasheets. 
For example, while the datasheet states that a 50 μm thick layer needs an exposure of 160 
mJ/cm
2
, 320 mJ/cm
2
 is usually used in practice. Following exposure, the silicon is 
immediately removed from the aligner and placed on a hot plate for a post-exposure bake 
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for a prescribed time. Still take the 50 μm thickness as an example, a bake at 65 °C for 1 
min and then at 95 °C for 6 min is utilized. The success of photolithography can be 
judged from the fact that the features of the mask appear in the photoresist layer after 
some time. After baking, the wafer is allowed for a sufficiently long time to cool down to 
room temperature. (Note: A sufficient cooling step is critical. Insufficiently cooled wafers 
will have the SU-8, especially the small and high aspect ratio structures, detached from 
the surface during the development step to be described below.) 
The final step for fabricating masters is development; the wafer is dipped into the 
SU-8 developer to remove unexposed photoresist. Usually the development times 
recommended by the datasheets are used as a guideline only as the rate of development 
varies depending on the strength of agitation and the specifics of SU-8 structures. Being 
close to the end point of development is indicated by the observation that the majority of 
unexposed SU-8 is dissolved. The wafer is rinsed with fresh developer and then isopropyl 
alcohol. If a white films forms after rinsing, the development process is not completed. In 
this case, the wafer is again immersed into the developer solution for another 15 s. The 
cycle of rinse and reimmersion may need to be repeated until a clean surface is obtained 
after rinsing with isopropyl alcohol. (Note: too long a development can also lead to the 
detachment of exposed SU-8 from the surface. It is acceptable that some unexposed SU-8 
remains on the wafer, as long as it does not interfere with the desired structures.) The 
exposed wafer is finally rinsed with DI water and blown dry with nitrogen. In this way, a 
master with the SU-8 features copied from the mask is formed. Before use, the master is 
usually inspected under a microscope to check for possible defects in the structures.  
145 
 
The top of a PDMS device is made by pouring the prepolymer, Sylgard 184 (Dow 
Corning, Midland, MI) onto the master and being cured at 70 °C. It is found that different 
curing times above 6 h achieve similar results. The cured PDMS is cooled down to room 
temperature and peeled off from the master. For the feature sizes < 5 μm, it is difficult to 
remove the PDMS without breaking the fine structures on the master. In this case, the 
master is first treated with trideca-fluoro-1,1,2,2,-tetrahydrooctyl trichlorosilane (Gelest, 
Morrisville, PA) by placing the master and an open dish with 2-3 drops of the silanizing 
agent together in a desiccator for 2 h, before pouring the PDMS prepolymer. The layer on 
SU-8 formed by the silane facilitates the removal of cured PDMS. To assemble a device 
with sealed channels, the PDMS top is placed on a piece of silicon or glass, which is pre-
cleaned by sequential rinse with methanol and DI water, through conformal bonding. If 
permanent bonding is needed, the PDMS piece is treated with oxygen plasma at 100 W 
for 30 s with a March Plasmod plasma system and then immediately bonded onto a 
substrate. 
Although the positive photoresist, AZ 5214-E (AZ Electronic Materials Corp., 
Somerville, NJ), has only been used for surface derivatization purposes in this 
dissertation, the fabrication process involving it is also included here for completeness. 
Compared to the SU-8, the AZ 5214-E is less viscous and easier to handle. First, a 4-inch 
silicon wafer (WRS Materials, Spring City, PA) is cut with a diamond pen into small 
pieces of suitable size for a single device, and the pieces are cleaned sequentially with 
acetone, methanol, and DI water and blown dry with nitrogen. The silicon pieces are 
dehydrated at a hot plate set at 100 °C for at least 3 min. The dehydrated pieces are 
transferred to the CEE 100 programmable spinner one by one; the wafer holder may need 
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to be changed to accommodate the size of silicon pieces. The AZ 5214-E is dispensed 
onto the silicon with a plastic dropper to cover the entire surface. Since the AZ 5214-E is 
not very viscous, usually air bubble removal is not needed. The process of spin-coating is 
set as follows: step 1: spinning at 500 rpm for 5 s, ramping at 100 rpm/s; step 2: spinning 
at 3000 rpm for 30 s, ramping at 300 rpm/s. Because the photoresist is only used as a 
protection layer to block certain area of a silicon substrate from silanization reactions, the 
exact thickness of the photoresist layer is not important here. There is no issue of 
photoresist accumulation at the edge of the wafer either with the AZ photoresist. The 
silicon piece is then put on a hot plate at 100 °C for 1 min for a soft bake. After cooling 
down, the silicon is exposed to UV through a transparency mask for 10 s in the same 
mask aligner used for the SU-8 wafer. For positive photoresists, the exposed area 
becomes soluble in the developer solution. The mask for surface patterning has a simple 
design with one half black and the other blank. The black-blank boundary is carefully 
aligned with the silicon substrate in the mask aligner so that about 2/3 of the piece is 
exposed to UV light. For the AZ 5214-E, a post-exposure bake is not necessary. The 
purchased developer solution is diluted with DI water in 1:1, and the exposed silicon 
piece is dipped into the diluted solution until the exposed photoresist is dissolved and a 
clear pattern is visible. During development, an occasional agitation can be applied. The 
development time is about 45 s with the conditions used here. After that, the substrate is 
rinsed with DI water and blown dry with nitrogen. Now the substrate is ready for surface 
derivatization. 
